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Bacterial interactions with each other and with host cells play a critical role in the 
pathogenesis of gonorrhea. Bacterial aggregation was observed to be mediated by the 
interaction between lipooligosaccharide (LOS) and the opacity-associated protein. In 
this study, I identified a gene encoding a beta-hexosaminidase (NagZ) in Neisseria 
gonorrhoeae that modulates gonococcal aggregation and biofilm formation. In 
comparison to the parental strain, a strain with the nagZ gene deleted produced a 
biofilm with increased mass. Scanning electron microscopy and confocal laser 
microscopy were able to visualize differences in the biofilms formed by the two 
strains. Biofilms formed by a strain deficient in nagZ were disrupted by addition of 
  
exogenously added purified NagZ. This is the first study to demonstrate that an 
enzyme thought to be restricted to peptidoglycan recycling is able to moonlight as 
biofilm modulator. NagZ could play an important role in promoting bacterial escape 
from a biofilm, along with previously characterized agents such as Nuc 
thermonuclease. Using strains defective in surface protein glycosylation, I 
demonstrate that the increase in biofilm formation seen in nagZ mutant is dependent 
on PglC-mediated surface protein glycosylation. This is the first study demonstrating 
the role played by surface glycoconjugates in gonococcal biofilm formation. I used 
bioinformatic analysis to study the diversity of the other major glycoconjugate on 
gonococcal surface, LOS. I identified significant differences in the LOS core 
structure between commensals and pathogens within the Neisseriaceae. I generated 
preliminary data suggesting that N. gonorrhoeae activate inflammasomes in epithelial 
cells, resulting in production of IL-18. While activation of inflammasomes does not 
affect production of other cytokines such as IL-8, IL-8 levels were reduced by using 
MyD88-inhibitors. Gonococcal-induced inflammasome activation in epithelial cells 
and production of inflammasome-dependent cytokines were further confirmed in 
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Chapter 1: Introduction 
1.1 Gonorrhea, its impact and significance:  
Gonorrhea, one of the oldest known diseases (1), is a sexually-transmitted 
infection caused by the human obligate gram-negative diplococci, Neisseria 
gonorrhoeae (gonococci, or GC). First described by Albert Neisser as the causative 
agent of gonorrhea (2), interest in studying the pathogen increased in the early 
twentieth century. The discovery of penicillin was a major step in fighting the 
disease, especially during the Second World War. While prevalence of disease 
peaked during 1970s, possibly due to a combination of factors such as increase in 
sexually active population, and preference of non-barrier contraceptives over barrier 
methods, the incidence has since then continually dropped. Recently, there has been a 
small uptick in disease. According to the Centers for Disease Control and Prevention 
(CDC), there were 334,826 cases of gonorrhea in the US in 2012, marking a 4.1% 
increase from 2011 (3). However, CDC also estimates that more than 800,000 people 
get infected with gonorrhea, with less than half of them being diagnosed and treated. 
There has also been a consistent and continual increase in the prevalence of 
cephalosporin-resistant gonorrhea, over the last two decades (4).  
Gonorrhea is currently being treated with a two-drug regimen (consisting of 
injectable ceftriaxone along with one of the two oral drugs, doxycycline or 
azithromycin), following increased resistance against even third-generation 
cephalosporins (Figure 1.1) (3, 5). In the last decade, strains with reduced 

















Figure 1.1 Incidence of gonorrhea. The incidence of gonorrhea in men and women, 
by age based on CDC data. The rate of incidence per 100,000 population is shown age 





Europe, Canada and the US (5). The CDC considers the threat of ceftriaxone 
treatment failure to be “imminent”, forcing it to increase surveillance and launch a 
response plan. N. gonorrhoeae primarily causes urethritis in men, and cervicitis in 
women. However, it has also been demonstrated to cause oral and rectal infections. In 
neonates, GC can cause conjunctivitis and dermatitis by contact transmission. Patients 
infected with GC have an increased risk of acquiring human immunodeficiency virus 
(HIV) (6). In addition, untreated women could go on to develop ascending infection 
of their genital tract resulting in pelvic inflammatory disease (PID), or disseminated 
gonococcal infection (DGI), which is associated with dermatitis and arthritis (7, 8). 
PID can also lead to other complications such tubal scarring resulting in infertility 
and predisposing women to ectopic pregnancy, while neonatal conjunctivitis can 
cause corneal scarring and blindness (9–11). Renewed interest in gonococcal research 
has occurred in light of these observations and the emerging threat of multidrug-
resistant strains. 
1.2 N. gonorrhoeae virulence determinants  
 The major surface virulence factors are porin, pili proteins, opacity-associated 
proteins, lipooligosaccharide (LOS), reduction modifiable protein, H.8 protein, IgA 
protease, aerobically-induced proteins and iron-binding proteins. Figure 1.2 
represents the various surface virulence determinants in Neisseria spp., and their 
corresponding ligands on the host tissue.  
 Porins are the most abundant outer membrane protein in Neisseria spp. They 








Figure 1.2 Virulence determinants of Neisseria. (A) Schematic representation of various 
surface virulence determinants of pathogenic Neisseria spp. and their corresponding ligands 
on host tissue. (B) Schematic representation of the various ligands (in host tissue) for Opa 




gonococci. Porins exhibit allelic variation, but there is very little variation of structure 
within a given strain. While meningococci has two paralogs of the por gene  
designated as porA and porB, gonococci have only one gene which is orthologous to 
the meningococcal porB. Previously referred as Protein 1 (P1), gonococci porin has 
been shown to elicit a strong immune reaction during infection. Porins are also 
involved in gonococcal invasion of cervical epithelial cells through C3R integrin and 
the scavenger receptor SREC (12). 
Porin was observed to translocate into host cell membranes, resulting in 
impairment of phagocytosis, actin polymerization, lysosome maturation and secretion 
of microbicidal peptides (13–15). PorB1b has been reported to induce calcium influx 
from outside the cells, resulting in apoptosis induction (16). Since an increase in 
intracellular calcium results in activation of NLRP3-mediated inflammasome, and 
there was inhibition of porin-induced apoptosis by treating with YVAD (a caspase 1 
inhibitor), it is possible that porins can also result in inflammasome activation (12, 
17). Porins also function as immunomodulators by binding and activation TLR2 (18). 
Porin 1A can impair complement-mediated killing by binding to complement factor 
H (19). These features, and porin’s ability to induce a T-cell dependent response 
make porin an ideal candidate for inclusion in vaccines, since the other major antigen, 
LOS, is T-cell independent (20, 21). 
 LOS is a glycolipid similar to LPS in other gram-negative bacteria but lacking 
the repeating oligosaccharide outer core (22–24). LOS molecules have a lipid 
component, commonly called lipid A, and a carbohydrate component, divided into 
















Figure 1.3 Schematic representation of neisserial LOS. The various enzymes involved in 
LOS biosynthesis are represented, in addition to the sugar moieties added by them. Phase 
variable enzymes are LgtD, LgtA and LgtG. In addition, the α-chain can also sialylated by Lst 





the characteristic “cytokine storm” seen in endotoxic shock (25, 26). In Neisseria, the 
outer core consists of three carbohydrate chains: α, β and γ. Some of the 
glycosyltransferases involved in outer core synthesis have been observed to be phase-
variable, resulting in antigenic variation of outer core structure (27, 28). The 
schematic in figure 1.3 shows the various enzymes involved in biosynthesis of LOS 
molecule, and phase-variable enzymes are denoted by an asterisk. In addition, the 
LOS can be decorated with host-derived sialic acid, which prevents recognition by 
the immune system. Sialylation of LOS reduces phagocytosis by neutrophils, 
complement-mediated bacterial killing, and binding of IgM and IgA antibodies (29, 
30).  LOS is essential for gonococcal survival (31). 
 Neisserial LOS, like LPS, has been shown to activate TLR4, with the help of 
CD14 and MD2 (24). Before LOS interacts with TLR4-MD2 heterodimer, it has to be 
extracted from the outer membrane by human proteins such as LBP or soluble CD14 
(32–34). The stability of LOS on the outer membrane can affect the 
immunostimulatory potential of the molecule by controlling availability of LOS. The 
immunostimulatory ability of LOS can be further be modified by decoration of lipid 
A with a phosphoethanolamine moiety. John CM et al observed that PEA increases 
the inflammatory potential of LOS, and that lack of a PEA in lipid A due to the 
absence of the lptA gene explains the reduced inflammation caused by Neisseria 
commensals (35). In addition, the lipid A PEA group was also found to modulate 
neisserial resistance against cationic antimicrobial peptides (36). Our lab had earlier 
characterized the lpt3 gene and showed by biochemical analysis that the Lpt3 




Lpt6 has been shown to add PEA to the same heptose. While the biological role PEA 
decoration of lipid A has been studied in great detail, the importance of PEA in LOS 
inner core region is not completely understood. 
 LOS has been shown to interact with Opa proteins, suggesting that Opa acts as 
a lectin (38, 39). Opa proteins impart some degree of opaqueness and shine in 
gonococcal colonies grown on solid translucent media. Interestingly, there is no 
relationship between colony opacity and expression of Opa proteins in meningococci 
(40). Opa proteins, also known as heat-modifiable protein or PII, are transmembrane 
proteins with eight β-sheets and four outer loops (40). Opa proteins are phase-variable 
due to changes in the repeated pentameric sequence (CTCTT) within their coding 
sequence (41, 42). The frequency of phase variation has been estimated to be between 
10-3 and 10-4 per generation (43). All eleven copies of the opa gene in gonococci have 
been found to have the pentameric repeats. Opa proteins have been found to play 
critical and diverse roles in the pathogenesis of gonorrhea. Opa can bind to HSPG 
receptors, independent of pili, and mediate invasion (44). They have also been shown 
to bind to CD66 receptors (a subtype of carcinoembryonic antigen-related cell 
adhesion molecule (CEACAM)). CEACAM family members are expressed in genital 
epithelial cells and neutrophils, suggesting a critical role for GC-CEACAM 
interaction (45). Transgenic mice expressing human CEACAM1 and CEACAM3 
have been developed to study GC interaction with host immune cells (46). GC 
binding to CEACAM3 in neutrophils induces opsonin-independent phagocytosis, and 
this has been shown to trigger a powerful cascade of Syk-dependent signaling 




known about the role of the complete Opa protein, it is also possible that frame-
shifting of the opa gene could result in an alternate protein being expressed with 
novel functions (40). The highly phase-variable nature of the protein also makes it an 
unlikely vaccine candidate in spite of a significant role in the pathogenesis of 
gonorrhea (21).  
 Pathogenic Neisseria secrete IgA protease has been shown to cleave LAMP1 
protein and cause lysosomal disruption in infected cells (40). Loss of the IgA protease 
is associated with defects in intracellular survival and transcytosis of polarized T84 
epithelial cell monolayers (48). Neisseria also express type IV pili, which plays an 
important role in invasion of epithelial cells. GC exhibit phase variation of pili as well 
as antigenic variation of the pilE gene which encodes the pilin subunit (40).  
1.3 Biofilm: Architecture, Organization & Significance  
         The idea of bacteria living as part of a larger community has been well-
established for almost a century, based on studies of Rhizobium and other soil bacteria 
(49, 50).  Bacterial acquisition of multicellular behavior has been shown to have 
happened multiple times independently, conferring evolutionary advantage through 
various mechanisms (49). One of the classical examples of transient bacterial 
multicellularity is biofilm formation (Figure 1.4) (51). Biofilms represent the oldest 
form of organization of life on earth (51). Stromatolites, dating back to 3.4 billion 
years, represent fossilized remnants of cyanobacterial biofilm (52). Biofilms are 
believed to contain more than 98% of all bacteria in the world, and more than 50% of 
earth’s biomass (53). Biofilms represent an organizational unit of microorganism, 










Figure 1.4 Examples of biofilm formed in various environments. Clockwise from top left 
are SEM images of a Proteus mirabilis biofilm formed on a urinary catheter, a S. aureus 
biofilm in a cardiac pacemaker, a fungal biofilm formed on contact lens surface, and a 





In a majority of biofilms, the matrix contributes over 90% of the dry weight. 
The matrix is composed of extracellular materials that act as a scaffold for the 
biofilm, and also contributes for attachment to the surface and for cohesion within the 
biofilm. The extracellular matrix can be composed of proteins, exopolysaccharides 
and extracellular DNA (eDNA) (54–56). The biofilm matrix i also protects the 
bacteria from antibiotics, toxins and other competing bacteria (55, 56). However, it is 
paramount to understand that naturally occurring biofilms are seldom formed by a 
single bacterial species (53). Studies on multispecies biofilms have not only revealed 
the level of complexity involved in bacterial interaction, but have also highlighted the 
limits of current technology in studying interaction between different species (57). 
The architecture of a biofilm determines the metabolic status in a given biofilm by 
virtue of changes in concentration, cohesion, charge, sorption capacity of the various 
components in the matrix, and three-dimensional properties of the matrix such as 
pores, distribution of pores and water channels (53). Biofilms exhibit various three-
dimensional architecture. They can be smooth and flat, rough, fluffy, mushroom-
shaped, or filamentous (56).  Some bacteria, such as P. aeruginosa and B. subtilis, 
form pellicles at the air-liquid interface under static aerobic conditions (58–60). Most 
biofilms also have variability in pore distribution (61–63). These pores, described as 
“water channels” play a critical role in transporting nutrients and removing waste 
products from various microenvironment in the biofilm (53). They possibly also 
provide conduits for soluble factors that play a role in bacteria-bacteria 
communication. The organization of biofilms also creates a gradient of nutrition and 




oxygenation has been shown to result in anaerobic respiration in biofilms especially 
in the bottom layers in P. aeruginosa and N. gonorrhoeae (64–66). Studies using 
microelectrodes to measure oxygen levels within the biofilm have demonstrated that 
there are variations in oxygen level on a micrometer scale. Multispecies biofilms have 
been observed in chronic wounds, marine sediments, urinary catheter, dental plaques 
and industrial sludge. Multispecies biofilms are a good way to study competitive as 
well cooperative interactions (67). P. aeruginosa was reported to kill Candida in 
biofilms (67). Similarly, Streptococcus mutans is killed by hydrogen peroxide 
generated by S. oligofermentans in multispecies oral biofilms. In addition, these 
biofilms facilitate horizontal gene transfer as observed in dental plaques. Cooperative 
interactions between bacteria in biofilms have been exploited to improve efficiency of 
microbial fuel cells (MFCs) (68, 69). 
Bacterial biofilms go through various stages over time (Figure 1.5). The role of 
biofilms in disease is well-established for oral infections and colonization of catheters 
and other devices. Bacterial biofilms have also been implicated in the pathogenesis of 
infected renal stones, bacterial endocarditis, infections in cystic fibrosis patients, 
chronic prostatits, biliary tract infections, otitis media, osteomyelitis, chronic 
tonsillitis, and necrotizing fasciitis (67). Bacterial biofilms have been implicated in 
providing a favorable environment for antibiotic resistance, because of the presence 
of suboptimal concentrations of antibiotics and a lower metabolic state that further 
impedes the bactericidal activity of antibiotics (70). In addition, biofilms have also 
been observed to promote horizontal transfer of antibiotic resistance. Biofilms are 












Figure 1.5 Structural evolution of biofilm. Free-floating or planktonic bacteria come in 
contact with each other and with a solid surface, forming microcolonies as they continue to 
aggregate (Initial attachment). As the biofilm is being formed, EPS production starts and the 
biofilm begins to stabilize (Biofilm formation). Production of EPS allows the biofilm to 
develop into a mature, complex, three-dimensional structure (stabilization). As the overall 
complexity and bacterial density increases, biofilms start maturing and continuously grow at 
the outermost layer while the innermost layer remains quiescent and anchors the biofilm to a 
surface. Over time, the biofilm degrades or begins to propagate by detachment of individual 
or small clumps of cells. This degradation and bacterial dispersal is usually mediated by 
enzymes and aided further by shear stress.  Shown are SEM images of gonococcal biofilm 





industrial equipment damage, industrial product contamination and hospital 
associated infections. However they also have potential applications in the food 
industry, bioenergy development, and astrobiology (53, 67, 70).  
1.4 Biofilm matrix structure and function  
         Bacterial biofilm matrix is composed of proteins, exopolysaccharides, bacterial 
outer membrane, and eDNA (56, 71). The majority of those are sourced from the 
biofilm forming bacteria. The matrix offers a three-dimensional scaffold for the 
biofilm and keeps the bacteria in close proximity, facilitating close interaction and 
retaining released cellular debris (56). Hence, the matrix functions as a chamber that 
facilitates recycling of bacterial debris. A list of various functions served by various 
components of biofilm matrix is given in Table 1.1.  
Polysaccharides are a major component of the biofilm matrix (55, 56). 
Advances in fluorescence microscopy such as Raman microscopy in combination 
with fluorescent lectin stains have furthered our understanding of the structure of 
these polysaccharides in EPS. The vast majority of exopolysaccharides are 
heteropolysaccharides composed of neutral and charged sugar residues, such as 
alginate (in P. aeruginosa), colanic acid (in E. coli), and PNAG (poly N-
acetylglucosamine in S. aureus). Some bacteria can produce more than one kind of 
exopolysaccharide (56). These heteropolysaccharides can be composed of different 
monomers, and also at different ratios. P. aeruginosa has been shown to produce 
three different kinds of exopolysaccharide - alginate, Pel, and Psl (54, 72). 
Homopolysaccharides are also found in EPS produced by bacteria such as 











Table 1.1 Components of biofilm matrix. List of various EPS components and their 





cellulose (56). EPS formed by different strains of the same species can have 
differences in their EPS components. Observations showing lack of biofilm formation 
by mutations that compromise EPS biogenesis demonstrate the vital role played by 
EPS in biofilm formation.  
 Biofilms possess an abundance of extracellular DNA (eDNA), facilitating 
genetic exchange (73). The source of eDNA could either be from lysis of a bacterial 
subpopulation (aided in part by autolysins) or by active secretion of DNA: some 
strains of N. gonorrhoeae that possess the gonococcal genomic island (GGI) secrete 
DNA by a Type IV secretion system (74, 75). In addition, eDNA can also function as 
a structural component, as evidenced by destruction of biofilms by treatment with 
DNase. eDNA has been shown to be a major structural component in biofilms formed 
by S. aureus, B. cereus, P. aeruginosa, N. meningitidis and N. gonorrhoeae (76–79). 
Studies on gonococcal biofilm have shown the different roles played by ssDNA 
versus dsDNA. While ssDNA was found to play a vital role in initiating biofilm 
formation, unlike dsDNA it was not incorporated in the mature biofilm (71). Targeted 
destruction of ssDNA only prevents biofilm formation but has no effect on preformed 
biofilms (71). The structural role of eDNA has also been observed to show significant 
differences depending on the organism studied (55, 56). For example, eDNA forms a 
grid-like structure in P. aeruginosa, it has been shown to form a network of fine 
strands and thicker ‘rope’ like structures in H. influenzae biofilm (81, 82).  
1.5 Other components of matrix, and mechanical properties of matrix: 
 The other major components of the biofilm matrix are proteins (enzymes and 




secreted or released by bacterial lysis. These enzymes have also been shown to have 
very diverse function, such as rearrangement of EPS into a more refractory polymer 
in marine stromalites, and promoting dispersal by degrading the EPS as observed in 
Actinobacillus actinomycetemcomitans (56).  
 Proteins can form structural components of a biofilm (83, 84). Extracellular 
proteins such as curli   play a quintessential role in biofilm formation by E. coli and 
Salmonella spp (85). Bacterial structures such as pili and flagella also provide 
proteinaceous structural components to biofilm (86).  
Lipids are also observed in biofilms formed by Rhodococcus spp., Thiobacillus 
ferrooxidans, Serratica marcescens and N. gonorrhoeae. Rhodococcus spp. biofilm 
has an EPS with hydrophobic properties that allow it to adhere to teflon and colonize 
waxy leaf surfaces (56). The lipids in gonococcal biofilms are derived from outer 
membrane vesicles released by the bacteria (87).  Outer membrane-like filaments 
seen in gonococcal biofilm have also been observed in vivo in cervical biopsy 
samples (87, 88). The hydrophobic nature of some components in the matrix   be 
caused by biosurfactants. These surface active molecules are believed to act during 
the initiation phase by promoting bacterial aggregation (56). The last and the most 
abundant component in biofilm matrix is water. The EPS matrix, being hygroscopic, 
provides a hydrated environment by retaining water and buffering against 
environmental fluctuations. However, the matrix seems to be able to sequester 




1.6 Biofilm formation, maturation, and dispersal:  
 Biofilms begin when individual bacteria aggregate to form microcolonies. This 
initial aggregation is aided in part by bacterial motility (89–91). For example, P. 
aeruginosa strains defective in flagellar motility and type IV pili were not able to 
form microcolonies (86). Pilus-negative Group A Streptococci (GAS) are defective in 
biofilm formation (92). Pilus-negative gonococcal strains formed thinner biofilm 
compared to pilus-positive strains (Unpublished observations). Sherlock et al also 
showed that intercellular TibA-TibA interaction contributes towards bacterial 
autoaggregation in E. coli (93). Other factors associated with increased bacterial 
aggregation are fimbriae, AIDA, curli fibers, Ag43 (all in E. coli), Bap (S. aureus), 
flagellin (C. jejuni), Opa and AutA (N. meningitidis), ShdA and MisL (Salmonella 
enterica) (39, 94–98). It is interesting to note that a vast majority of these bacterial 
adhesins are autotransporters. The role of interbacterial interaction in biofilm is 
clearly demonstrated by Veiga et al when they expressed a chimeric protein with 
domains from Jun and Fos in E. coli (99). Fos and Jun form heterodimers through 
strong interaction between their coiled coils (99). In addition to promoting 
interbacterial aggregation, bacterial adhesins such as curli fibers and Ag43 also 
facilitate attachment of bacteria to biotic and abiotic surfaces. Curli fibers also 
promote binding of bacteria to host extracellular components such as laminin, 
fibronectin, and plasminogen (85). Similarly in P. aeruginosa and UPEC, 
components of CUP (Chaperone Usher Pathway) fimbriae promote bacterial surface 
adherence (100). Other factors shown to be involved in bacterial attachment to 




N. gonorrhoeae), MSCRAMM family of proteins, Embp, protein A, FnbpA, FnbpB, 
and SasG (S. aureus and S. epidermidis) (101–105) .  
 The initial aggregation and surface contact between bacteria and a surface can 
lead to changes in gene expression, up regulating genes encoding proteins involved in 
matrix formation (106). High levels of 3,5-cyclic diguanylic acid (cyclic-di-GMP) 
promote expression of adhesins such as CdrA in P. aeruginosa, which then binds to 
Psl, and stabilizes the biofilm (107). Cyclic-di-GMP has also been found to affect 
production of alginate, Pel and Psl (108).  There is evidence that cell-to-cell 
communication plays a key role in regulating matrix production and biofilm 
strengthening. The quorum sensing system, called Agr (accessory gene regulator) in 
S. aureus, upregulates biofilm-degrading enzymes such as proteases, and 
downregulate expression of adhesins (109). Quorum sensing systems have also been 
implicated in biofilm maturation by increasing eDNA amounts in the matrix. 
Although eDNA increases in quantity over time because of bacterial lysis, mature P. 
aeruginosa biofilms were less sensitive to DNase digestion than younger biofilms, 
suggesting a more significant contribution from other components of EPS rather than 
DNA in improving structural stability (56). Contrastingly, experiments in our lab 
using gonococci did not show any difference in DNase sensitivity vis-a-vis age of  the 
biofilm. Gonococcal biofilms grown for various time periods were all equally 
sensitive to DNase treatment and were almost completely dispersed (Unpublished 
observation). The complex interaction between the various components of the matrix, 
including exopolysaccharide, adhesins and eDNA complemented by increasing 




in S. aureus), form a biofilm scaffold to support the multiplying bacteria during this 
phase. The mature biofilm thus serves as a safe haven for the resident bacteria, 
offering protection against host immune cells and other toxic molecules.  
 As the bacterial population increases, the biofilm stability begins to be 
compromised due to a plethora of reasons, not limited to loss of structural stability, 
susceptibility to shear stress, lack of nutrient percolation, accumulation of toxic 
metabolites, and release of biofilm degrading enzymes (110). Levels of cyclic-di-
GMP are inversely correlated with bacterial dispersal from a biofilm (111). This 
dispersal appears to be coordinated and highly regulated, as a subpopulation of cells 
undergo lysis and release nutrients which act as cues for dispersal of another 
subpopulation (111). The dispersal cells undergo changes in gene regulation by down 
regulating genes involved in biofilm formation such as pilA, and upregulate other 
genes such those encoding flagella and proteins involved in chemotaxis (110). 
Recently, incorporation of D-amino acids in peptidoglycan   trigger dispersal in 
Bacillus spp., S. aureus, and P. aeruginosa (112).  
 In general, there are three modes of dispersal namely erosion, sloughing and 
seeding (111). Erosion refers to continuous bacterial release over the entire lifecycle 
of the biofilm at a low level, whereas sloughing refers to sporadic bursts of 
detachment of huge parts of the biofilm. Seeding dispersal is characterized by central 
hollowing where small clusters of bacteria leave the matrix resulting in a hollowing. 
These are believed to help in the formation of new pores which can facilitate access 
of nutrients to remote parts of the biofilm. These mechanisms can either be either 



















Table 1.2 Mechanisms of biofilm dispersal. List showing the various mechanisms by which 






whereas passive dispersion is mediated by external agents such shear stress, human 
intervention (eg. brushing of teeth) and predator grazing (eg. phagocytosis) (111). 
Table 1.2 lists the various mechanisms behind biofilm dispersal. 
 EPS-lysing enzymes are significant contributors for bacterial dispersal. Table 
1.3 shows a list of various EPS-degrading enzymes in different bacteria. These 
enzymes can be classified into DNases, proteases, and glycolichydrolases. While 
EPS-degrading enzymes breakdown the covalent links, surfactant molecules 
produced by bacteria can breakdown biofilm by destroying non-covalent linkages. 
Bacterial dispersal agents are also aided partly by host-derived factors such as higher 
body temperature, norepinerphine, extracytopalsmic ATP, increased nutrients that 
promote biofilm destruction (110). Another class of agents that promote biofilm 
dispersal are bacteriophages. The bacteriophage Pf4 has been shown to promote 
dispersal of P. aeruginosa str. PAO1 biofilm (113). Although some bacteriophages 
have been known to encode an EPS-degrading enzyme, the mechanism behind phage-
induced biofilm dispersal is not clearly understood. It is hypothesized that during the 
later stages of biofilm development, the switch from lysogenic to superinfective 
phage form drives cell death, which is believed to dump intracellular enzymes that 
can aid bacterial dispersal. In support of this hypothesis, deletion of CRISPR 
elements can reduce bacterial swarming and increase biofilm formation (111).  
1.7 Gonococcal biofilm formation:   
 Neisserial biofilm studies, initiated by Igor Stojilijkovic showed biofilm 


















Table 1.3 List of EPS-degrading enzymes. Table shows some of the characterized biofilm-





coverslips (114–116). Apicella et al extended the studies to N. gonorrhoeae, showing 
that GC can form biofilm in a continuous flow chamber (88). GC were observed to 
form microcolonies, which eventually developed into biofilm on the surface of 
urethral and cervical epithelial cells. The biofilms had a tridimensional structure 
characterized by a matrix interspersed with water channels to supply nutrients to the 
deeper regions of the biofilm. Interestingly, using lectin-binding they also 
demonstrated the role of outer membrane vesicles (OMVs) in biofilm formation (88). 
Since N. gonorrhoeae does not make any EPS, it is believed that the OMVs play an 
important role by giving structural support to the biofilm matrix. OMVs have also 
been shown to contain large amounts of DNA (117).  
 The role of DNA in GC biofilm matrix was established when it was 
demonstrated that nuc knockouts formed thicker biofilms compared to the wildtype 
strains (118). The nuc gene encodes a nuclease, which was found to be active on both 
single-stranded as well as double-stranded DNA. Further studies on incorporation of 
DNA in GC biofilms revealed that it was predominantly dsDNA that was 
incorporated in mature biofilms, although biofilm formation was reduced by treating 
with Exonuclease I, which specifically destroys ssDNA (80). This suggests different 
roles for ssDNA and dsDNA in biofilm initiation and maturation. A similar role for 
dsDNA was suggested by studies in meningococci, where it was found that eDNA 
released by cell lysis contributed to shear force resistance (76).  
 The importance of studying GC biofilms is highlighted by observation of 
biofilm formation in patients diagnosed with gonococcal cervicitis (87). TEM 




surfaces in vivo. The significance of GC biofilm formation should also be seen in 
light of observations in N. meningitidis where it was found that 30 percent of carriage 
isolates formed biofilm in comparison to only 12.5 percent of invasive strains (114). 
Our lab observed similar trend when gonococcal isolates from cervix were compared 
with isolates from gonococcal isolates from the blood of the same patients; the blood 
isolates form less biofilm when compared to the cervical isolates (Nadia Kadry, 
unpublished observation). This observation correlates with studies on N. meningitidis 
where Lapann et al observed that clonal complexes that are unable form biofilm, such 
as ST-11 and ST-8, tend have a poor colonization ability but higher transmission rates 
(76).  
1.8 Gonococcal protein glycosylation: 
 
Gonococcal pili   be heavily glycosylated post-translationally by addition of 
either an O-linked trisaccharide or O-linked disaccharide depending on the expression 
of pglE gene (119). Phase variation of the glycosylation pattern adds another level of 
heterogeneity to the outer membrane of Neisseria spp. This was demonstrated in a 
study by Virji et al where they observed that differences in strength of adherence of 
meningococci to epithelial cells was affected by both the primary sequence of pilin 
subunits as well as glycosylation status of pilin subunits (120). Adherence rates were 
higher with N-linked glycosylation of pilin subunits. While the various proteins 
involved in pilin glycosylation have been characterized, bacterial glycosylation in 
















Figure 1.6 Protein glycosylation system in Neisseria spp. Schematic representation of the 
various enzymes involved in glycosylation of surface proteins in N. gonorrhoeae and N. 
meningitidis, showing sequential action of various enzymes which add the sugar moieties on 
to undecaprenyl-lipid carrier and then transfer the glycosyl moiety to proteins in the 





 Systematic peptide-based assays have revealed the extent of protein 
glycosylation in prokaryotes. The gonococcal protein glycosylation system has been 
well characterized although the heterogeneity of surface glycans is still being 
uncovered. The promiscuity of bacterial glycosylation was demonstrated by Vik et al 
when they observed that the pilin glycosylation system was able to glycosylate other 
non-pilus associated proteins such as AniA, PotF and DsbA (121). These proteins 
were glycosylated at their serine residues, similar to the pilE glycosylation at Ser-63 
site. Allelic variations in pglH, which encodes a protein involved in gonococcal 
protein glycosylation downstream of PglC, were observed to result in addition of N-
acetylglucosamine and peptidoglycan fragments to surface proteins (Figure 1.6)(122). 
The role of bacterial glycosylation in promoting bacterial aggregation and biofilm 
formation has been extensively shown by studies on serine-rich adhesins (123). 
Streptococcal glucosyltransferases Gtf1 and Gtf2   be involved in GlcNAc decoration 
of Fap1 protein and the Fap-1-like serine-rich proteins, which play important role in 
bacterial aggregation (124). This GlcNAc decoration has been shown to promote 
biofilm formation in S. parasanguinis (124). Similar observations have been made in 
pneumococci and A. baumannii (125, 126). 
1.9 Innate and adaptive immunity:  
 The innate immune system is the first line of defense against pathogens in 
humans and mammals. Innate immunity differs from the other arm of human 
immunity, adaptive immunity, in that it is present from birth, and does not confer 
long-term immunity (127). Studying the interaction between the different arms of 




asymptomatic gonorrhea. Understanding how gonococci would suppress immune 
response would help us develop better vaccines and diagnostic tests for better 
diagnosis of asymptomatic disease. 
 Innate immunity protects against pathogens by employing rapid, non-specific 
and highly conserved mechanisms while the adaptive immune system prepares to 
mount a more specific and robust response, which might take days to weeks to 
develop. Innate immunity involves macrophages, dendritic cells, neutrophils, mast 
cells, basophils, eosinophils, natural killer cells, and γδ T cells (128). At a molecular 
level, proteins of the complement system and pattern-recognition receptors (PRRs) 
are major components of innate immunity. Adaptive immunity, unlike innate 
immunity, creates a specific and targeted immune response with immunological 
memory (127). There are two major adaptive immune responses - antibody 
production and a cell-mediated response. While antibody production is mediated by 
B-cells and cell-mediated response is orchestrated by T-cells, there is significant 
interaction between the two responses (127).  
 There are three major groups of T-cells - CD8 T cells, CD4 T cells and γδ T 
cells. CD8 cells are cytotoxic cells involved in directly killing pathogens or 
dysfunctional host cells by using perforin and granzyme. There are numerous 
subgroups of Th cells such as Th1, Th2, Th9, Th17, Th22 and Treg cells (129). Th 
cells play a crucial role in modulating adaptive immune response. While Th1 cells, 
which secrete IFN-γ, activate bactericidal macrophages, cytotoxic CD8 cells and 
induce B-cells to make opsonizing antibodies, Th2 cells are characterized by a 




at mucosal surface, which produce IL-17, IL-17F and IL-22 (130). They differentiate 
in response to STAT-3 activating cytokines IL-6, IL-21 and IL-23, along with IL-1β 
and TGF-β. By mediating neutrophilia and secretion of antimicrobial peptides by 
epithelial cells (131), Th17 cells play a vital role in fighting mucosal infection (130). 
All the diverse and discrete units of the immune system generally communicate 
through chemicals referred to as cytokines. 
Cytokines are an assortment of soluble polypeptides and glycoproteins, similar 
to hormones but are not endocrine-derived (132). Cytokines generally act in a local 
environment, in autocrine and paracrine fashion. Cytokines play a crucial role in 
maintaining homeostasis as well as responding to any disturbance in homeostasis 
(133–135). The balance between levels of proinflammatory cytokines such as IL-1, 
IL-6, IL-8, TNF-α and anti-inflammatory cytokines such as IL-10 and TGF-β is 
important in preventing a disproportionate immune response (136). Epithelial cells, 
which form the first line of defense against the external environment, can secrete 
cytokines following stimulation by other cytokines or by pathogens (137). 
  Epithelial cells in bronchial airway secrete IL-10 constitutively which prevents 
an excessive immune response against pathogens (138). Alteration in epithelium-
derived levels of IL-6 has been observed in patients suffering from asthma (139). The 
immune regulatory role of airway epithelium and gut epithelium has been well-
characterized (140). Cytokines derived from epithelia in the female genital tract have 
also been studied, although their role in infection is not completely understood. 
Studies in mice and rat have shown that epithelial cells in the FRT are able to produce 




epithelial cells exposed to E. coli whereas L. rhamnosus had no effect, suggesting that 
epithelial cells are able to differentiate between commensals and pathogens (141).  
  From an anatomical perspective, innate immune barriers include skin, mucosal 
layers in the gastrointestinal tract, respiratory tract and urogenital tract, and 
conjunctival layer in eyes. Among these, one of the busiest portals of bacterial entry 
is the mucosal layer, which shows the importance of mucosal immunity in human 
health. The mucosal immune system consists of epithelial cells (and extra epithelial 
secretions) and mucosa associated immune cells, which can either be unorganized or 
organized into specialized lymphoid tissue referred as mucosa-associated lymphoid 
tissue (MALT). The epithelial layer observed in endocervix and ectocervix, the two 
regions first infected by N. gonorrhoeae, are fundamentally different (1, 141). While 
the epithelial layer in the endocervix forms a tight polarized monolayer of columnar 
epithelial cell characterized by tight and adherens junctions, the ectocervix is lined by 
multiple layers of loosely adherent squamous epithelial cells (141).  
Epithelial cells form a physical barrier against bacterial invasion, aided in part 
by tight junction formation between neighboring cells (142). The integrity of tight 
junctions can be measured using an ohmmeter that measures the electrical resistance 
across the epithelial monolayer (143). Tight junction barrier function is also regulated 
by cytokine production and growth factors. Previous work in our lab has established 
how gonococci was able to disrupt tight junction in polarized epithelial cells (144). 
The physical barrier is further reinforced by mucosal secretion which also contains 
microbicides such as human β-defensins (HBDs), human α-defensin-5 (HD5), 




as surfactant protein A (SP-A), and cathelicidins, of which only LL-37 is found in 
FRT (145). GC resistance against cationic antimicrobial peptides (CAMPs) is 
mediated by the decoration of LOS with phosphoethanolamine (PEA), and by the 
action efflux pumps such as NorM (146). Mucus secretions mainly consist of mucins 
and are also rich in antibodies. Soluble mucins are believed to prevent bacterial 
pathogens from invading epithelial cells by binding and trapping the bacteria (147). 
In addition to the challenging task of identifying potential pathogens from 
beneficial commensals, the mucosal layer in female reproductive tract (FRT) has “to 
balance protection with procreation” (148). This balance is aided in part by the 
hormonal regulation of immune cells. The immune cells as well as epithelial cells in 
FRT respond to cyclical changes in levels of estrogen and progesterone. Estrogen 
(E2) has been shown to reduce LPS-induced IL-6 production and transepithelial 
electrical resistance (TEER) in epithelial cells (141, 148). E2-driven keratinization of 
vaginal epithelial cells prevents GC infection of those cells. As a result vaginal 
gonorrhea is limited to prepubescent girls (149).  
Epithelial cells also express pattern-recognition receptors such as Toll-like 
receptors (TLRs) and NOD-like receptors (NLRs) (128). TLRs are evolutionarily 
conserved transmembrane proteins that recognize either exogenous PAMPs or 
endogenous danger-associated molecular patterns (DAMPs). Ten human TLRs and 
their corresponding ligands have been characterized, as listed in Table 4. TLRs 
function as dimers. All TLRs except TLR2, which forms heterodimers with either 
TLR1 or TLR6, function as homodimers (150, 151). The receptors form a dimer 







Table 1.4 TLRs and their distribution in human cells. Table lists their subcellular location, 










Figure 1.7 TLR activation and signaling. (A) Activation of TLRs result in downstream 
recruitment of adaptor molecules such as MyD88 and MAL. TLR signaling is mediated by 
two distinct pathways, MyD88-dependent and MyD88-independent. Following recruitment 
and activation of the adaptor molecules, transcription factors such as NF-	  κB and AP-1 are 
activated, resulting in transcription of genes encoding inflammatory cytokines such as IL-8 
and IFN. (B) Schematic representation of various ligands on GC surface that activate TLRs 





pathways, namely a myeloid differentiation primary-response protein 88 (MyD88)-
dependent pathway resulting in expression of inflammatory cytokines and a MyD88-
independent pathway resulting in expression of type I interferons. Following ligand-
induced dimerization, the TLRs bind to MyD88 and MyD88-adaptor-like protein 
(MAL) or to TIR domain-containing adaptor protein inducing IFNβ (TRIF) and 
TRIF-related adaptor molecule (TRAM) (151, 152). Following binding of signaling 
adaptor molecules IRAKs and TRAFs, there is activation of MAPKs, JKNs, p38 and 
activation of transcription factors, NF-κB and, AP-1, CREB and IRFs (Figure 1.7). 
TLR activation results in production of pro-inflammatory cytokines. 
Cells in all regions of FRT express TLRs 1-6, as shown by 
immunohistochemical techniques, although vaginal and ectocervical epithelial cells 
do not to express TLR4 (153). The absence of TLR4 in lower female reproductive 
tract could be a result of the need to tolerate useful commensal bacteria such as 
Lactobacillus spp. and diphtheroids (141, 154, 155). Gonorrhea in females primarily 
affects the endocervical epithelial cells, but could ascend into the endometrial 
epithelial cells in the uterus, resulting in pelvic inflammatory disease (PID) (1). The 
endocervical epithelial layer is composed of a monolayer of polarized epithelial cells. 
Primary endocervical epithelial cells express TLRs 1-3, and TLR6, while primary 
endometrial epithelial cells expressed TLRs 1-9 (156). Primary endometrial epithelial 
cells only respond to the TLR3 agonist poly (I:C), suggesting that additional signaling 
factors such as soluble CD14 might be needed to stimulate primary endometrial 
epithelial cells in solitary culture (157). HEC 1-B cells (human endometrial 




 The other classes of pattern recognition receptors are NODs, RIG-like receptors 
(RLRs), C-type lectin receptors (CLRs) and NOD-like receptors (NLRs). While 
NOD1 recognizes diaminopimelate-containing peptidoglycan, this is limited to gram-
negative bacteria. NOD2 is activated by muramyl dipeptide, which is produced by 
both gram-negative and gram-positive bacteria (128). Although TLRs and NODs both 
activate NF-κB, they use different adaptor proteins. Unlike TLRs which are 
transmembrane proteins and detect extracellular or membrane-bound ligands, NODs, 
RLRs and NLRs are cytosolic and are activated by cytosolic ligands (159). More than 
23 NLRs have been identified in humans. NLRs, on activation by danger-associated 
molecular patterns or by bacterial products such as flagellin, form an inflammasome 
complex resulting in caspase 1 activation, inflammatory cytokine production and cell 
death.  
1.10 Inflammasomes and their role in bacterial infection  
 An inflammasome is a high molecular weight protein complex formed in the 
cytosol, which serves as a platform to recruit proinflammatory caspases such as 
caspase 1, caspase 4 and caspase 5 in humans, and caspase 11 and caspase 12 in mice, 
although only recruitment of caspase 1 has been well-established (159, 160). While 
the canonical inflammasome activation pathway involves NLR-medicated 
recruitment and assembly of ASC and caspase-1, caspase-1 activation has also been  
shown to be established by a novel mechanism involving caspase-11 (160). The non-
canonical inflammasome activation pathway involves sensing cytosolic LPS, and 
















Figure 1.8 Inflammasome activation and its effects. Schematic showing the various steps 
involved in (A) inflammasome assembly and caspase 1 activation,  (B and C) various stimuli 
that play activate the different inflammasomes, (D) biological function of caspase 1-dependent 





 Inflammasomes are activated in response to very diverse stimuli, ranging from 
intracellular ion changes to presence of crystals such as urate. Bacterial toxins such as 
lethal toxin (LT) from B. anthracis and bacterial type III and type IV secretion 
systems activate inflammasomes (161). In general, inflammasome activation has been 
shown to require two signals: Signal 1 works through the NF-κB pathway to increase 
expression of NLRs, pro-caspase, pro-IL-1β and pro-IL-18, and signal 2 activates the 
NLRs and triggers the assembly of inflammasome (160). The NLRs are auto inhibited 
in the absence of a ligand. In the presence of a suitable stimuli or ligand, the 
autoinhibition is released and NLR molecules then oligomerize through NBD and 
PYD domains (Figure 1.7) (160).  
 Inflammasome activation, irrespective of the stimuli or the mechanism, results 
in production of IL-1β, IL-18, and secretion of alarmins such as HMGB1 (160). 
Although IL-1β production is primarily inflammasome-mediated, there are other 
mechanisms of inflammasome-independent IL-1β production including caspase-8, 
ripotosome-(involving RIP1), and TNF receptor (TNFR)-mediated mechanisms 
(159). Proteinases such as matrix metalloproteinases (MMPs), cathepsin G, elastase, 
streptococcal exotoxin B have been shown in vitro to cleave pro-IL-1β into its active 
form (162). In addition to inducing cytokine production, inflammasome activation 
also protects against microbial infection by another mechanism called pyroptosis 
(163). Pyroptosis is a programmed cell death mechanism, unlike necrosis, but highly 
proinflammatory, unlike apoptosis. Pyroptosis is characterized by cytokine release by 
microvesicle shedding, cytokine secretion through caspase 1-dependent pores, 




Pores, roughly with a diameter of 1.1 to 2.4 nm, are formed on the plasma-membrane, 
which allows water influx and osmotic lysis (163). 
 The downstream effects of inflammasome activation include IL-1β-mediated 
neutrophil influx, production of prostoglandins and leukotrienes, a strong Th17 
response and induction of fever. IL-1β, unlike IL-1α, is not expressed in all cells and 
limited mainly to myeloid cells (164). In addition, IL-1β needs to be cleaved into its 
active form before it can be secreted. The receptors for both IL-1β and IL-18, contain 
a Toll-IL1 related (TIR) domain and can signal through the adaptor protein MyD88 to 
result in NF-κB activation (164). IL-1β has been shown to activate a Th17 response 
by blocking IFNγ. In addition, IL-1β has also been shown to inhibit TGFβ- induced 
Foxp3 expression, both of which result in an augmented Th17 response. Although 
Th17 response has been found to be protective in STIs such as vaginal candidiasis, it 
had no protective function in a murine model of gonorrhea (165). In contrast, 
inhibition of Th17 response resulted in development of a protective immunity in the 
mice model for gonococcal infection (166). The other product of inflammasome is 
IL-18. Unlike IL-1β, IL-18 has been shown to promote skewing of immune response 
towards Th1 response, along with IL-12 or IL-15 (167). In some cases, IL-18 also 
promotes a Th17 response along with IL-23. Occasionally IL-18 has also been shown 
to perform a protective role by suppressing T-cell mediated response in mice model 
of H. pylori infection, preventing  T-cell mediated tissue damage (168).  Not all 
inflammasome activation is protective and useful. Under some conditions, IL-1β and 










Table 1.5  Biological function of IL-1β  and IL-18. Diseases in which IL-1β and IL-18 play 





1.11 Immune response against GC  
 Study of host immune response against N. gonorrhoeae is important to 
understand the absence of protective immunity and to understand subclinical nature 
of gonococcal infection. Studies in human volunteers have been limited due to 
practical and ethical considerations. Even these studies, however, were limited to 
male volunteers. Ramsey et al showed elevated levels of IL-8, IL-6, TNF-α and IL-1β 
in urine of male volunteers 48 hours after infection (169). However, only IL-1β levels 
correlated with onset of symptoms and an increase in leukocyte in urine sediment, 
whereas the other three cytokines increased as early as 2 hours post-inoculation. The 
correlation of IL-1β with onset of clinical symptoms implies that the source of IL-1β 
are migrating inflammatory cells. Production of IL-8 and IL-6 by endocervical 
epithelial cells has also been demonstrated. This is believed to be independent of 
TLR4 because endocervical epithelial cells lacked both TLR4 as well as MD2 (156).  
 N. meningitidis can activate TLR2 and TLR4 in THP1 cells (human monocyte 
cell line) using LOS (170). While this activity is not affected by sialylation of LOS or 
the presence of a capsule, other LOS variations affect cytokine levels in cell culture 
models (35, 170, 171). GC activation of TLR2 was observed to enhance infection of 
HIV-1 infection of T lymphocytes (172). The neisserial outer membrane proteins, 
porin, H.8 protein and Lip activate TLR2 and induce expression of inflammatory 
cytokines (24). Gonococci release peptidoglycan fragments outside, which are TLR2 
agonists (24). Using CD4+ T cells, Mallet et al showed that gonococci-derived 
hexose monophosphate acted as a PAMP and induced cytokine production (173). 











Figure 1.9 GC modulation of innate and adaptive immune response. (A) GC can activate 
inflammasome in macrophages, resulting in IL-1b production and pyronecrosis of APCs. (B) 
GC interaction with DCs results in IL-10 production and PDL-1 and PDL-2 mediated apoptosis 
of PD1-expressing Th cells. (C) GC interaction with CD4 cells induces production of IL-10, 
TGF-b and IL-6. IL-10 and TGF-b inhibit Th1 and Th2 activation. TGF-β and IL-6 induce 
Th17 cell response, leading to the recruitment or induction of innate defenses such as PMNs 





proinflammatory cytokine production the mechanism underlying asymptomatic 
infections are not yet completely understood (21).  
Recently, Duncan et al showed that GC can activate cathepsin B in THP1 cells 
which in turn activated NLRP3 inflammasome resulting in subsequent production of 
IL-1β (174). In monocytes, porin has been shown to induce calcium influx and cause 
apoptosis, which was inhibited by using a caspase 1-specific inhibitor zYVAD-FMK 
(16). Since calcium influx has been reported to cause NLRP3 inflammasome 
formation, it is possible that porin can also induce inflammasome-mediated IL-1β 
release. While the role of IL-1β in gonorrhea is yet to be studied in detail, it has been 
shown as a very potent pro-inflammatory cytokine involved in pathogenesis of other 
autoimmune diseases such as rheumatoid arthritis, gout, and inflammatory bowel 
disease (159). It is suggested that GC-induced pyroptosis could lead to death of APCs 
and tissue monocytes, resulting in problems associated with development of 
protective immunity (Figure 1.9  ) (21, 174).  
Gonococci interaction with CD4+ T cells has been shown to result in production 
of anti-inflammatory cytokines IL-10 and TGF-β (175). TGF-β has been shown to be 
responsible for mediating the switch from Th1/Th2 response to Th17 response in 
mice experiments, resulting in a strong innate immune response but weak adaptive 
immunity (166). Blocking TGF-β resulted in a stronger adaptive immune response. 
While these experiments explain the lack of adaptive response, the strong innate 
response seen in lab experiments using cell lines contradicts the feeble innate 
response seen in gonorrhea among female patients. In this study, I strove to 




volunteer patients undergoing hysterectomy. Previous organ culture experiments with 
N. gonorrhoeae were limited to fallopian tube (FT) explants (176). Cytokine profile 
of GC incubation with FT explants showed secretion of TNF-α, IL-6, IL-1β.  The FT 
model was useful to identify the correlation between TNFα levels and sloughing of 
ciliated epithelial cells, which could result in scarring and infertility associated with 
PID. However, fallopian tube infections are late events in the natural history of 
gonorrhea and are not representative of the vast majority of gonococcal infections. 
1.10 Rationale 
 Gonorrhea is the second-most prevalent bacterial STI after Chlamydia 
infection (177). There are an estimated 820,000 infections per year in the US, with 
about 30% of them being resistant or showing reduced susceptibility to at least one 
antibiotic. The disease has the highest incidence in the sexually active age groups of 
20 and 30 years (177). The general focus of this dissertation is to identify the 
diversity surface glycoconjugates in the Neisseriaceae, and study the role of 
glycoconjugates in gonococcal interaction with each other. Modulation of surface 
virulent determinants is one of the most common ways bacteria can manipulate the 
outcome of host-pathogen interaction. Our lab has focused on gonococcal LOS, its 
biosynthesis, and its role in immune response. Gonococci have a very elaborate 
surface protein glycosylation mechanism originally identified as pilin glycosylation 
system. The promiscuity of this system leads to numerous other surface proteins 
being glycosylated, leading to extensive surface glycoconjugate diversity. I 
hypothesized that modulation of surface protein glycosylation would be able to affect 




In the first part of this study, I look at other neisserial species and use 
bioinformatics tools to identify LOS biosynthetic genes in commensal Neisseriaceae 
strains. Using this approach has helped identify the differences in LOS between 
neisserial commensals and pathogens (22). Neisserial LOS is a major virulence 
determinant that activates TLR4 on host cell surface. LOS also a plays an important 
role in bacteria-bacteria interaction, by binding to Opa protein. This interaction can be 
characterized by measuring biofilm formation by the gonococci. While gonococcal 
biofilm formation has been demonstrated on biopsy samples from patients with 
gonorrhea, the mechanisms behind biofilm formation, maturation, bacterial escape 
and eventual degradation have not been identified. Biofilm formation has been 
observed to help bacteria evade immune system by attenuating host proinflammatory 
responses, leukocyte-mediated killing and complement activation. Understanding 
biofilm formation by gonococci would help us understand the role of biofilm in 
asymptomatic infections. In order to study this, I have developed techniques to form 
and visualize gonococcal biofilm on abiotic and biotic surfaces. I have used human 
cervical tissue samples to look at biofilm formation in a biologically relevant system 
and used scanning electron microscope to visualize and quantify biofilm formation In 
this study, I have identified a novel function for an intracellular enzyme previously 
thought to be only involved in peptidoglycan recovery pathway.  
In the final part of this study, I demonstrate gonococcal activation of 
inflammasome in epithelial cells as well as cervical explant tissue. Inflammasome 
activation by gonococci has been shown in human monocytic cell lines. Pyroptosis, 




destroying immune cells. The focus of the study is on the role of surface glycosides 
on N. gonorrhoeae and to understand their role in bacteria-bacteria interaction as well 
as bacteria-host interaction.  
1.11 Specific Aims and Approaches 
1.11.1 Aim 1: To characterize the diversity of LOS structure among the various 
strains Neisseriaceae.  
While the LOS biosynthetic genes in neisserial pathogens, N. meningitidis and   N. 
gonorrhoeae, have been well characterized, little is known about the LOS 
biosynthetic genes in commensal strains and their distribution among the various 
commensals. Using an in silico approach I will identify the different biosynthetic 
genes and their distribution among neisserial strains.  
1.11.2 Aim 2: To understand how gonococci modulate glycosylation of their 
surface proteins to impact bacteria-bacteria interaction and biofilm formation.  
Bacteria-bacteria interaction plays a major role in biofilm formation and bacterial 
escape from biofilm. I show the role of surface glycosylation and its modulation by 
NagZ in neisserial biofilm formation. Using confocal microscopy and scanning 
electron microscopy to visualize biofilm, I aim to understand the structure of 




1.11.3 Aim 3: To understand how gonococci interaction with host cells affects 
inflammasome-mediated immune response.  
Bacterial interaction with epithelial cells resulting in an inflammatory response is the 
hallmark of acute disease. Using a fluorescence assay to detect activated caspase 1, I 
show that gonococci can activate inflammasome in epithelial cells. I also used a 
human cervical explant model to study interaction of N. gonorrhoeae with host tissue 





Chapter 2: Lipooligosaccharide diversity in Neisseriaceae 
and their analysis using genomic data 
 
2.1 Introduction  
 Members of the genus exhibit diverse LOS phenotypes. While N. meningitidis 
is an opportunistic pathogen, N. gonorrhoeae is an obligate pathogen (40). However, 
meningococcal infections are associated with a higher rate of morbidity and mortality 
in comparison to gonococcal infections (178). Colonization with N. lactamica has 
been found to induce cross-reacting antibodies that protect against meningococcal 
meningitis, while none of the other commensals elicit any clinically observable 
immune response (179). This suggests a spectrum of virulence among Neisseria spp, 
with N. meningitidis on one end and all the other commensals at the other end with N. 
gonorrhoeae in between the two. As seen in figure 2.1, phylogenetic analysis showed 
that most of the commensals cluster away from the pathogens except N. lactamica, N. 
cinerea and N. polysaccharea, (180). The phylogenetic clusters also correlate with the 
observed spectrum of virulence within Neisseriaceae. The reasons for these varied 
host-pathogen interaction are still not completely understood.  
 Pathogenic Neisseria spp. elicit a stronger innate immune response than any of 
the commensal Neisseria spp (35). The major virulence determinants in Neisseria are 
capsule (present only in N. meningitidis), colony opacity-associated proteins (Opa and 













Figure 2.1. Phylogenetic analysis of the various members of Neisseriaceae. Maximum 
likelihood tree based on the concatenated sequence of 896 core neisserial genes shared by all 
members. The carrier meningococci strains are marked by an asterisk. The phylogenetic 
relationship is consistent with observed virulence of each of these organisms, which is 
represented on the right with decreasing degrees of virulence from bottom to top, with red 
being associated with significant disease, and green indicating the absence of disease. Figure is 





majority of neisserial commensal strains lack Opa proteins, porin homologs, and 
functional pili (180). LOS is a naturally occurring variant of lipopolysaccharide 
(LPS). LOS, unlike LPS, lacks the O-repeating carbohydrate polymer, and instead 
typically has a shorter oligosaccharide chain in its place. Both molecules however 
have a core polysaccharide unit covalently connected to the lipid A moiety. Lipid A 
typically has six fatty acid tails attached to two glucosamine residues in various 
combinations in different organisms (22, 27). On a given bacterium it has been 
estimated that it contains approximately 2 million lipid A residues (181).   
 Pathogen-Associated Molecular Patterns (PAMPs), such as LPS are recognized 
by Pattern Recognition Receptors (PRRs), such as TLR4. Although LOS lacks the O-
carbohydrate, it has still been shown to activate TLR4 (182). Neisserial LOS, by 
causing widespread activation of TLR4 and hence ‘cytokine storm’, causes the 
endotoxic shock seen in fulminant meningococcal shock (183). The biologically 
active portion of both LOS and LPS has been established as the lipid A portion (184). 
Lipid A activates TLR4 by forming a heterodimer of TLR4 and MD-2 (185, 186). 
Myeloid Differentiation factor-2 (MD-2) is a co-receptor for LPS/LOS (187). MD-2 
is essential for expression of TLR4 on the cell surface as well as down- stream 
signaling following activation of TLR4 (186). Structural studies of this LPS-TLR4-
MD-2 complex have shown that LPS bridges TLR4 and MD-2 by having five of the 
six fatty acid tails buried in hydrophobic pocket in MD-2 and the other fatty acid 
forms a hydrophobic interaction with the conserved phenylalanine in TLR4 (188). 
 The first step in LOS activation of TLR4 is extraction of individual LOS 




binding protein (LBP), an acute phase protein, secreted by hepatocytes (34). LBP-
LOS complex is readily detected by both soluble and membrane-bound CD14 (a GPI- 
linked protein on the surface of myeloid cells), which further relays LOS to host cell 
membrane-bound receptors. While LBP is not essential for LOS binding to CD14 
(but it significantly enhances LOS binding to CD14), CD14 is essential for LOS’ 
proinflammatory activity (189). LBP enzymatically transfers LOS to CD14, both 
membrane-bound and soluble. Transfer of LOS to TLR4 by CD14 leads to the 
formation of TLR4-MD2-LOS complex, that then dimerizes, leading to downstream 
signaling resulting in a myriad of effects (190). Two different pathways, namely 
MyD88-dependent and MyD88-independent, mediate the downstream activation. 
Distinct cytokine profiles have been observed for each one of these pathways. While 
the MyD88-dependent pathway results in secretion of TNFα, IL-1β, MCP-1 and MIP-
3α, the MyD88-independent pathway releases IFNβ, EDRF, IFNγ inducible pro- tein 
10 (IP-10) and Type-I IFN (190). Bacterial LOS/LPS can activate both pathways. 
LOS-activated TLR4-MD-2 complex turns on the downstream cascade, resulting in 
nuclear translocation of transcription factors such as NF-κB, which promote 
expression of proinflammatory cytokines. Variations in the levels of cytokine, 
induced by TLR4 activation, have been observed between different types of LOS 
molecules (191). 
 Neisserial pathogens induce a wide array of cytokines by TLR2- and TLR4-
mediated pathways. Absence of a TLR4 response was found to be associated with 
increased bacterial load and defective neutrophil-mediated killing in mice models of 




would lead to a favorable environment for gonococci, LOS is essential for viability of 
non-capsulated Neisseria. Gonococci have evolved to engage TLR4 and still survive 
the innate immune response. Neisserial engagement of TLR4 was found to induce a 
specific subset of cytokines leading to a Th17 response, which precludes development 
of immune memory, induces neutrophil infiltration, and secretion of cationic 
antimicrobial peptides (165). Experiments using anti-TGFβ to divert immune 
response from Th17 to Th1/Th2 response resulted in faster clearing of primary 
infection, and protection against secondary infection (166). While the mechanism by 
which gonococci guides TLR4 activation to a Th17 response is still not understood, it 
is evident that the bacteria can modulate host response by engaging with TLR4. 
 Modulation of immune response by changing LOS/LPS structure has also been 
observed in other species. The oral pathogen Porphyromonas gingivalis expresses 
diverse forms of LPS which have been observed to activate both TLR2 and TLR4 in 
mice (193). P. aeruginosa has been found to change between penta-acylated and 
hexa-acylated versions of LPS in cystic fibrosis and bronchiectasis respectively. This 
difference in LPS structure was detected by human TLR4 (194). Commensal bacteria, 
which also express LOS, are continually sampled by the immune cells in the 
lymphoid tissue but, paradoxically, fail to elicit a sustained local inflammatory 
response (195). Jarvis et al showed that neisserial pathogens induce significantly 
higher levels of TNFα from human monocytic cells in comparison to commensal 
species (35). The differences in the physical structure of LOS between commensals 
and pathogens could be one of the reasons for the difference in their inflammatory 




polymorphism, can also explain the wide variations in clinical presentation of 
gonorrhea.  
 The biosynthetic pathway of LPS has been well characterized, and the enzymes 
involved have been targets for developing novel antibiotics. In Neisseriaceae, LOS 
has been observed to undergo high frequency variation in structure due to phase 
variation of LOS biosynthetic genes and the relaxed specificity of some of the 
enzymes involved in LOS biosynthesis (24, 27). This variation has been implicated in 
disease pathogenesis as well as immune evasion. While LOS biosynthesis on 
neisserial pathogens has been well studied, not much is known about LOS structure in 
the commensals. Limited studies on commensal LOS suggest that LOS variability is 
higher in commensals than among the pathogenic strains. Our lab had earlier showed 
that one of the commensal strains was able to express an LPS, unlike any of the other 
neisserial species. The O-repeats were identified as disaccharide repeats of rhamnose 
and GlcNAc (196). While N. sicca is a commensal species, this particular strain was 
isolated from a fatal case of endocarditis. It is possible that production of an O-repeat 
could have increased the pathogenicity of this strain. More importantly, this 
highlights the heterogeneity of LOS structure in neisserial commensals. 
 I took a bioinformatic approach to identify the LOS biosynthetic genes in 
neisserial commensals. In this study, I used bioinformatic tools to identify genes 
involved in LOS biosynthesis in various Neisseriaceae to predict the diversity of LOS 
structure among the different species. I also identified patterns of gene distribution 
that correlated with empirical data about the corresponding bacteria-host interaction, 




hypothesized that those commensal-restricted genes could be responsible for 
attenuating TLR4-mediated immune response. In order to test this hypothesis, I 
knocked out one of the commensal-restricted genes and one of the pathogen-restricted 
genes and used those mutants to compare TLR4 response before and after gene 
knockouts.  
 This study is important for understanding LOS biosynthesis among 
commensal species in Neisseriaceae. In addition to demonstrating the diversity of 
LOS structure among the various species I also attempted to define the structure-
function relationship of neisserial LOS using the LOS inner core as proof-of-concept. 
Identifying structure-function relationship of LOS will help us design better vaccines. 
This work was published in PloS One in 2011 in a paper titled “Sequence –based 
predictions of lipooligosaccharide diversity in Neisseriaceae and their implication in 
pathogenicity”. While the sequencing, assembly of sequencing reads and 
identification of ORFs was performed by Clint Miller and Daniel Sommer, I 
generated all the figures shown in this chapter.  
2.2 Materials and Methods  
2.2.1 Commensal Neisseria sequencing  
         Chromosomal DNA for N. sicca 4320, N. sicca DS1, N. polysaccharea 342, N. 
sicca NS19, and N. meningitidis 44 was isolated using the method described in 
Maniatis et al. The DNA sequence of each of these samples was determined by the 
Genomics Resource Center at the University of Maryland School of Medicine, 




of contigs for each commensal (197). The sequence reads were assembled by Daniel 
Sommer and curated for submission tin NCBI by me. The genomic sequences were 
submitted to NCBI: N. sicca 4320, GenomeProject ID #60861; N. sicca DS1, 
GenomeProject ID #60863; N. polysacchareae 342, GenomeProject ID #60865; N. 
lactamica NS19, GenomeProject ID #60867; and N. meningitidis 44, GenomeProject 
ID #60869. 
2.2.2 Mummer alignments  
         Unique regions of the contig sequences of N. sicca 4320 were determined by 
alignment with the contig sequences of the other identified commensals using 
Nucmer, a component of the Mummer software package (198). The alignments were 
filtered to remove repeat alignments leaving a 1-to-1 alignment between N. sicca 
4320 and the other sequenced commensal. Regions not aligning were identified as 
unique to N. sicca 4320. This work was performed by Clint Miller and Daniel 
Sommer.  
2.2.3 Geneious  
         The contig sequences of the commensals were imported into the program 
Geneious (Geneious Inc, New Zealand). Custom BLAST databases of each 
sequenced commensal were compiled to use for further analysis. Geneious was used 
to manage all sequences and to construct the sequence figures found in this 
manuscript. 
2.2.4 ORF annotation  




ORFs predicted. The amino acid sequences of the predicted ORFs were extracted and 
used as queries in BLAST searches of the various NCBI and custom databases. The 
ORFs were annotated by Clint Miller and me.  
2.2.5 Bioinformatic BLAST screen of Neisserial sequence  
The custom commensal BLAST databases were searched to identify sequences with 
similarity to glycosyltransferases. ORFs showing similarity to the sequences were 
used as a query in a BLAST search of the nr database to confirm similarity to putative 
O-repeat biosynthesis genes. 
2.2.6 THP1Xblue Assay  
         THP1Xblue cells were obtained from Invivogen and grown in appropriate 
selection media to maintain the transfection. The cells have alkaline phosphatase gene 
under NFκB-promoter. The cells were seeded at 10e5 cells per well in 96 well plate 
and treated with bacteria at an MOI of 10 for 6 hours. The supernatant was collected 
and assayed using the Quantiblue (Invivogen) substrate, which turns blue if alkaline 
phosphatase is expressed as a result of NF-κB activation (199). The results are 
measure using a spectrophotometer and relative levels compared.  
2.3 Results 
2.3.1 Analysis of KDO transferases in Neisseriaceae 
 Lipid A is connected to the hydrophilic portion of LOS by KDO, which is 
added by KDO transferase while the lipid IVA moiety is still attached to the inner 




structure with four fatty acid tails instead of the usual six. The other two tails are 
added after the two KDO groups are added to lipid IVA, resulting in what is referred 
to as KDO2-Lipid A. The KDO transferase in E. coli has been shown by Raetz et al to 
be bifunctional, meaning it can add both the KDOs onto lipid IVA before the ‘late’ 
acyltransferases begin acting (200). The ‘late’ acyltransferases add the final two fatty 
acid tail to KDO2-Lipid IVA. However, bacteria such as H. influenzae have a KDO 
transferase that is monofunctional and C. trachomatis possesses a trifunctional KDO 
transferase (183).  
 Since KDO transferase’s functionality cannot be determined by sequence 
analysis, I used sequence of kdkA gene, which encodes the second KDO transferase in 
Haemophilus spp. to search for the second KDO transferase among all the available 
neisserial genomes. I did not identify any sequence with homology to kdkA, which led 
us to conclude that neisserial KDO transferase or WaaA protein is a bifunctional 
enzyme. The data in figure 2.2, shows that all neisserial species have a highly 
conserved waaA gene as seen by the consensus logo for neisserial pathogens, 
commensals N. cinerea and N. lactamica, and the other neisserial commensals. 
Consensus logos are a graphical representation of sequence alignment where the 
relative size of each letter (representing an amino acid) corresponds to the frequency 
of the amino acid among all the sequences used to generate the logo. The pathogens 
all have uniformly large sized letters representing their amino acids implying very 
little variability between the two species and the many strains used for sequence 
alignment. The commensals appear to have conserved in most parts of the protein, 












Figure 2.2 WaaA is highly conserved within Neisseriaceae. (A) Consensus logo created 
using the translated sequence of waaA from various neisserial strains. (B) Neisserial rfaC 
sequence compared against the E. coli waaA, C. trachomatis waaA and H. influenzae waaA. 
Neisserial waaA had highest similarity with the bifunctional waaA sequence from E. coli.  The 
DNA sequences used for this analysis were N. gonorrhoeae strains; 1291, 35/02, DGI18, 
DGI2, F62, FA19, FA6140, MS11, PID1, PID18, PID24-1, PID332, SK-92-679 and SK-93-
1035 [sequences from the Broad Institute], FA1090 (accession no. AE004969); and 
NCCP11945 (accession no. CP001050). DNA sequences for N. meningitidis were NS44 
(DCS, unpublished sequence), 053442 (accession no. CP000381), FAM18 (accession no. 
AM421808), 22491 (accession no. AL157959-1), MC58 (accession no. AE002098.2), alpha 
14 (accession no. AM889136.1). Commensal Neisserial strain DNA sequences were: 
Neisseria cinerea ATCC 14685 (accession no. ACDY00000000); N. elongata subsp. 
glycolytica ATCC 29315 (accession no. ADBF00000000); N. flavescens strain SK114 
(accession no. ACQV00000000) and strain NRL30031/H210 (accession no. ACEN00000000); 
N. lactamica ATCC 23970 (accession no. ACEQ00000000), Y92-1009 (Project ID: 50739), 
ST-640 (Project ID: 13472), and strain NS19 (DCS, unpublished sequence); N. mucosa ATCC 
25996 (accession no. ACDX00000000) and C102 (Project ID: 38747); N. polysaccharea 
ATCC 43768 (accession no. ADBE00000000) and NS342 (DCS, unpublished sequence); N. 
sicca ATCC 29256 (accession no. ACKO00000000), 4320 (DCS, unpublished sequence) and 
DS1 (DCS, unpublished sequence); Neisseria sp. oral taxon 014 str. F0314 (Project ID: 
49701); and N. subflava NJ9703 (accession no. ACEO00000000). The DNA sequences for 
Haemophilus influenzae were: Rd KW20 (accession no. L42023), 86-028NP (accession no. 
CP000057), PittEE (accession no. CP000671) and PittGG (accession no. CP000672. The DNA 
sequences for Chlamydia trachomatis were: strain 434/Bu (accession no. B0B9V8) and strain 





of each amino acid. Comparison of neisserial waaA sequence against waaA sequence 
from E. coli, C. trachomatis and H. influenzae (panel B, figure 2.2) shows that 
neisserial waaA has highest similarity with the monofunctional waaA from E. coli. 
This suggests that all neisserial species should express LOS with two KDO molecules 
connecting the inner core to lipid A, which is supported by previous analysis of 
neisserial LOS using mass spectrometry. 
2.3.2 Distribution of heptosyl transferases among Neisseriaceae 
 Structural analysis of gonococcal and meningococcal LOS shows that they have 
two heptose molecules in the inner core, which have the α- and β-chain linked to each 
one of them. The first heptose is added by RfaC and the second heptose is added by 
RfaF. In order to study the distribution of rfaC gene among neisserial commensals, I 
identified putative rfaC from all the neisserial genomes by BLAST and aligned them. 
As shown in panel A of figure 2.3, the synteny was identical in all the neisserial 
genomes. While there was virtually no variation among gonococcal strains in the 
RfaC protein sequence as seen in the consensus logo representation of gonococcal 
RfaC, meningococcal strains differed significantly within only 8 strains (panel B of 
figure 2.3). The sequences in N. lactamica and other commensals exhibited even 
more variability. In addition, mutations in the stop codon in commensals resulted in 
the readthrough adding between 4 and 16 amino acids to the protein. The reason for 
the high degree of conservation in gonococcus unlike the other neisserial species is 
not very clear.  
 I looked at distribution of rfaF gene among the neisserial species by BLAST 













Figure 2.3 Analysis of the rfaC region in the Neisseriaceae. (A) Genomic organization of 
the rfaC region. The gene pncA encodes pyrazinamidase/nicotinamidase, and the gene etfB 
encodes an electron transfer protein. (B) Sequence logo alignment of the rfaC gene from the 
various sequenced neisserial strains. Same strains as listed the previous figure were used for 





possessed an ORF with greater than 88% similarity across the entire sequence, 
suggesting that all neisserial species possess at least two heptose residues in their 
LOS as well as the selective pressure acting on maintenance of rfaF gene. The 
selective pressure is further highlighted when I looked at the synteny which was 
highly different between the pathogens and commensals and even within the various 
commensal strains, as represented in figure 2.4.  
2.3.3 Elongation of alpha chain with lgtF in Neisseriaceae 
 The alpha chain begins by adding the first sugar on to the first heptose in the 
core region. This sugar, glucose, is added by LgtF. The genomic organization of lgtF 
was analyzed among all the neisserial species. In pathogenic species, lgtF and rfaK, 
which encodes a N-acetylglucosamine transferase, form a two gene cluster. 
Experimentally it has been demonstrated that LgtF can add a glucose to the first 
heptose only after RfaK has finished transferring a GlcNAc to the second heptose. 
This could explain the reason the two genes are clustered together in the genome.  
 Pathogenic species and the closely related commensals, N. lactamica and N. 
cinerea, possessed both lgtF and rfaK. Figure 2.5 shows that the synteny was also 
conserved among the multiple strains in the four species. However, N. elongata has 
an ORF encoding N-acetyl galactosamine transferase instead of rfaK. The other 
commensal neisserial species encoded a fusion protein with the N-terminal half being 
similar to LgtF and the C-terminal half being similar to the GalNAc transferase seen 
in N. elongata. Since the function of the novel two-domain glycosyltransferase has 









Figure 2.4 Analysis of the rfaF region in the Neisseriaceae. The flanking genes encode: 
ogt, O-methylguanine-DNA methyltransferase; smpB, RNA-binding protein, proA, gamma-
glutamylphosphate reductase, csp, cold shock protein; hyp, hypothetical protein; dnaJ, Heat 















































































































































































































elongate their LOS via a sugar other than glucose. We also observed that the synteny 
was variable within the rest of neisserial commensals.   
2.3.4 Distribution of gamma chain N-acetylglucosamine transferase  
 I examined the distribution of rfaK gene among the different strains by 
performing BLAST analysis using N. gonorrhoeae FA1090 rfaK as template. I 
discovered that all the pathogenic species possessed an ORF with 100% identity to 
our template. The closely related commensals N. lactamica, N. cinerea, and one strain 
of N. polysaccharea possessed an ORF with 95% identity. All strains that possessed 
both lgtF and rfaK had the same genomic organization, with the same flanking genes. 
None of the other commensals had any sequence with similarity to RfaK. Searching 
the commensals using sequence information of the flanking genes showed that the 
two genes were not linked. This suggests that the ability to extend a gamma chain by 
adding GlcNAc was limited to pathogens and closely-related commensal 
Neisseriaceae.  
Previous experimental work in our lab has shown that LOS from N. sicca 4320 
had three heptose residues instead of two. This suggested that commensals could 
possibly extend their gamma chain by adding a third heptose instead of GlcNAc. I 
used the E. coli DH1 heptosyl transferase (WaaQ) sequence to search the neisserial 
genomes, since E. coli has been shown to have three heptoses in the inner core region 
of its LPS. All the neisserial strains that lacked RfaK, possessed a gene that encoded a 
putative protein with >50 % identity to E. coli WaaQ. Table 2.1 shows the 














Table 2.1 Distribution of genes involved in LOS core synthesis. Distribution of genes 
involved in addition of LOS core heptose (rfaC) and extension of gamma chain (rfaK and 
waaQ) is shown above. Members of Neisseriaceae appear to have two different ways to 






target the same acceptor molecule. The mutually exclusive distribution of these two 
genes suggests that neisserial strains possess two basic core structures; one with a 
gamma GlcNAc and one with a third heptose in place of GlcNAc.  
2.3.5 Modification of LOS with sialic acid  
 As described earlier, sialylation of LOS protects the bacteria from complement-
mediated killing and leads to increased virulence. However, GC does not possess the 
synthetic machinery to make sialic acid and instead scavenges CMP-NANA from the 
host, and uses a sialyltransferase (Lst). I screened all the neisserial genomes using Lst 
sequence from FA 1090. All the pathogenic strains possessed Lst with more than 97% 
identity to FA 1090 Lst. Among the commensals, except N. lactamica and N. 
polysaccharea, there was no hit matching Lst sequence. Figure 2.6 shows the 
genomic organization of lst. For strains that did not contain Lst, the genomes were 
screened with flanking ORFs from N. gonorrhoeae FA 1090 (both cytochrome c and 
isocitrate dehydrogenase). It appears that N. cinerea had deleted lst gene since it has 
the same flanking sequence as N. lactamica and N. polysaccharea. None of the other 
commensals possessed lst gene as shown, possibly due to the lack of selective 
pressure for sialylation in the absence of a strong immune response against the 
commensals. 
2.3.6 Distribution of other putative LOS biosynthetic gene  
 The alpha chain is elongated by a series of enzymes that are clustered together. 
These enzymes LgtA, LgtB, LgtC, LgtD and LgtE have been well characterized and 

























































































































































































































































































Figure 2.7 Genomic organization of the lgt gene cluster. The lgt gene cluster in N. 
gonorrhoeae strain F62 is flanked by two ORFs, glycyl tRNA synthase and a conserved 
hypothetical protein. Various organizational structures of the lgt genes were found in the 
pathogens, N. lactamica, N. cinerea, and N. polysaccharea, as indicated. All other 
commensal organisms tested had the glycyl tRNA synthase and a conserved hypothetical 




























Figure 2.8 Genomic organization of the putative LPS biosynthetic gene cluster. The 
numbers contained within the arrows refer to open reading frames found on Contig 56 that 
contained genes with homology to LPS biosynthetic genes. There were 21 ORFs. ORFs 11, 
15, 18, 19 and 21 are not numbered as they were too small to fit in the figure. All ORFs were 
compared to the organization as seen in strain N. sicca 4320. A solid black ORF indicates that 
the gene was found in the designated location. A stippled ORF indicates that the gene is 
present in a location elsewhere on the chromosome. Missing ORFs were not found in the test 
organism. All strains are as designated. If no species identification is present, it indicates that 
all strains from that species had the same genomic organization. The numbers located in the 
ORFs refer to the following proteins, which had the highest degree of similarity to proteins 
found in the NCBI database: 1) Rrf2-linked NADH-flavin reductase; 2) Unknown protein; 3) 
UDP-glucose dehydrogenase; 4) Lipopolysaccharide biosynthesis translocase; 5) 
Oligosaccharide repeat unit polymerase Wzy; 6) Capsular polysaccharide biosynthesis 
glycosyl transferase capM; 7) Glycosyl transferase); 8) UDP N-acetyl galactosaminyl 
transferase; 9) Putative carbamoyl phosphate synthase large subunit, short form; 10) 2-
Haloalkanoic acid dehalogenase; 11) Methionyl tRNA formyl transferase; 12) Pleiotropic 
regulatory protein; 13) Nucleoside-diphosphate sugar epimerase; 14) Polysaccharide export 
protein (Wza); 15) Low-molecular weight protein-tyrosine phosphatase (Wzb); 16) Tyrosine-
protein kinase (Wzc); 17) CidA-associated membrane protein CidB; 18) Holin-like protein 
CidA; 19) LysR family regulatory protein CidR); 20) Oxidoreductase; 21) Oxygen-






both gonococci and meningococci, whereas various combinations of these five genes 
have been observed in N. lactamica, N. cinerea and N. polysaccharea. None of the 
other commensals had any of the genes in the lgt cluster, although the flanking genes 
were present (figure 2.7). This suggests that the commensal LOS has a different 
structure compared to pathogens, consistent with published data. Of recent interest in 
our lab has been N. sicca 4320 since I showed that it expressed a lipopolysaccharide 
unlike other members of Neisseriaceae (196). The LPS bands show up as a ladder 
pattern in tris-tricine gel because of variations in O-antigen length. Comparison of N. 
sicca 4320 genomic DNA with meningococcal and gonococcal genomes resulted in 
identification of ORFs unique to N. sicca 4320, as shown in figure 2.8. The putative 
LPS biosynthetic genes also showed significant identity to those seen in E. coli.  
Figure 2.8 also lists the name of each of those ORFs while table 2.2 shows the 
genomic similarity of those LPS biosynthetic genes from N. sicca 4320 compared 
with other neisserial species. I observed that a majority of those genes are missing in 
the pathogens while still being present in other commensals. The identification of 
these LPS biosynthetic genes provides the theoretical basis to explain the LPS O-
antigen observed in N. sicca 4320. 
2.3.7 Structure function relationship of neisserial LOS  
 Comparative bioinformatic analysis of commensal and pathogenic neisserial 
genomes showed us the distribution of various genes and their correlation with 
bacteria-host interaction. I determined that the lack of O-antigen biosynthetic genes 
correlates with the greater immunostimulatory behavior since none of the pathogens 




and pathogens differed significantly. Table 2.3 shows the distribution of various 
genes involved in biosynthesis of LOS core region. While all pathogens and closely 
related commensals N. lactamica, N. polysaccharea and N. cinerea possessed RfaK 
protein, the other commensals had WaaQ protein, suggesting that inner core in 
commensals has a third heptose instead of a GlcNAc attached to the second heptose. I 
also observed that genes for Lpt3 and Lpt6, which add a PEA moiety to the second 
heptose in the core region, are absent in a majority of the commensals but present in 
all the pathogenic strains. Inner core substitution of GlcNAc with heptose, and lack of 
inner core decoration with PEA strongly correlated with commensal behavior, as did 
expression of O-antigen instead of a truncated alpha chain.  
 Commensal LOS is less immunoreactive in comparison to LOS from neisserial 
pathogens (35). Figure 2.9 (Panel A) shows that the pathogenic bacteria N. 
gonorrhoeae was able to induce more TNF- α than the commensals N. lactamica and 
N. subflava. PEA decoration of lipid A was observed to be responsible for the 
difference in immunoreactivity between pathogens and commensals. I hypothesized 
that differences in overall charge in inner core can also affect LOS immunoreactive 
potential by modulating LOS extraction the bacterial outer membrane. Computer 
simulation models of LPS and experimental data show the role of divalent cations in 
increasing LPS stability (figure 2.10). Divalent cations have been observed to form 
adducts that act as glue to bind neighboring LOS molecules, stabilizing the outer 
membrane. I hypothesized that an increase in overall negative charge of LOS core 
regions would mean a stronger cation-mediated cross-linking, making it harder for 




      
 
 
    
   
   
   
   
   
   
  
   
   
   
   
   
   
























































Table 2.3 LOS biosynthetic gene distributions among Neisseria species. Filled boxes 
correspond to a gene that is present in all the completed genomes available for that species. 








commensal LOS core region has three heptose molecules as opposed to two in 
neisserial pathogens, the commensal LOS core region has a relatively more negative 
charge with respect to neisserial pathogens. I knocked out waaQ gene in N. sicca 
4320 and rfaK gene in N. gonorrhoeae F62. N. sicca 4320 ΔwaaQ resulted in an LOS 
that appeared to be shifted slightly down compared to wildtype, suggesting loss of a 
heptose (panel B figure 2.9). Unlike neisserial pathogens where loss of rfaK results in 
loss of alpha chain elongation as well, there was no such effect on the O-antigen 
elongation in N. sicca 4320 on deleting waaQ (panel B figure 2.9). 
 The immunostimulatory potential was compared by incubating wildtype 
bacteria and the corresponding isogenic mutant with THP-1Xblue cells, which 
express an NF-κB/AP-1-inducible reporter system to monitor TLR-induced NF-
κB/AP-1 activation. Figure 2.9 shows the relative levels of activation by each strain. I 
observed that there was a statistically significant increase in immunostimulation by N. 
sicca 4320 ΔwaaQ compared to the wildtype strain, and knocking out rfaK gene 
reduced NF-κB/AP-1 activation in our human monocytic cell line in comparison to N. 
gonorrhoeae F62 wildtype strain. One possible explanation for the evolutionary 
selection for an LOS that is more immunostimulatory in pathogens is that having a 
less negative core region makes it harder for cationic antimicrobial peptides to 
interlace themselves between the LOS molecules, making pathogenic strains less 
sensitive to CAMP-mediated killing compared to commensal strains. Not having a 
highly immunostimulatory LOS also allows the commensal strains to escape host 
immune response, which they are not well equipped to survive. I tested all four strains 



















Figure 2.9 Differences in LOS correlate with TLR4 activation. (A) TNF- α produced by 
THP-1 cells after incubation with N. gonorrhoeae, N. lactamica, and N. subflava for 6 hours 
were measured by ELISA. (B) 16.% Tris-tricine gel of LOS preparation from N. sicca 
wildtype (lane 1) and waaQ deletion strain (lane 2). Inset image corresponds to the lower 
most band on LOS gel. This inset makes no sense as it does not look like the top panel.  Ge 
trid of it. (C) Relative levels of NF-κB activation measured using THP-1Xblue cell line, 
which secretes alkaline phosphatase (SEAP) on NF- κB activation. THP1-Xblue cells were 
treated with N. sicca 4320 wildtype, N. sicca 4320 ΔwaaQ, N. gonorrhoeae F62 wildtype or 
N. gonorrhoeae F62 ΔrfaK. The supernatant were collected and SEAP activity estimated by 
using a substrate that turns blue on cleavage by SEAP. Shown below the graphs is 






itself between neighboring LPS molecules in a stoichiometric fashion. This allowed 
me to indirectly measure the overall charge of the LOS core and lipid A region in 
each strain, since strains with a lower polymyxin MIC would mean a more negatively 
charged core region which makes it easier for polymyxin to intercalate. Figure 2.9 
(Panel C) shows that while knocking out waaQ only slightly increased the MIC in 
commensals, N. gonorrhoeae F62 ΔrfaK had a fourfold decrease in MIC compared to 
wildtype strain.  
2.4 Discussion  
         This study was undertaken to determine the genetic potential of the 
Neisseriaceae with respect to LPS/LOS expression making use of advances in 
genomic sequencing. The data indicate that neisserial LOS possesses two basic core 
structures; one that possesses a gamma chain N-acetylglucosamine and one that 
contains a third heptose. The presence of the third heptose was found in strains that 
rarely caused disease, while the presence of the gamma chain N-acetylglucosamine 
was associated with pathogens. However, two commensal strains expressed a gamma 
chain N-acetylglucosamine, N. lactamica and N. cinerea. The inability of N. 
lactamica (most closely related to N. meningitidis) to cause disease relates to its 
inability to express a capsule. Colonization of nasopharyngeal mucosa by N. 
lactamica has been observed to correlate with protection against development of 
meningococcal meningitis, suggesting development of cross-reactive protective 
immunity. With regard to N. cinerea, the inability of N. cinerea to cause disease 
could be related to its inability to sialylate its LOS, however other factors may also be 




look at diversity of LOS profile in Neisseriaceae using a bioinformatics approach. 
 The importance of LOS in neisserial pathogenesis is illustrated by the high 
degree of sequence conservation in the genes needed for LOS biosynthesis in the 
pathogens. It is further substantiated by the presence of homopolymeric runs of 
guanines in key genes involved in LOS biosynthesis, which leads to phase variable 
expression of LOS. I was unable to identify any homopolymeric runs, or other 
repeated sequences in commensal LOS biosynthetic genes, suggesting that the 
expression of LOS in commensal strains is invariant. The alteration in LOS structure 
seen in the commensal organisms suggests that the third heptose modification may 
play an important role in modulation LOS/LPS mediated toxicity. In order to test this 
hypothesis, I created a mutant strain of N. sicca 4320 unable to add a third heptose to 
its LOS inner core. Similarly, a gonococcal strain lacking the ability to add a GlcNAc 
in its LOS core region was created as well. Using these strains, I show that changes in 
LOS inner core can alter TLR4 stimulation in host cells. It is possible the difference 
in TLR4 stimulation is at the level of LOS extraction from bacterial outer membrane 
by LPS-binding proteins, rather than at the level of LOS-TLR4 binding since it is the 
lipid A portion that interacts with TLR4 rather than inner core portion of LOS. 
LOS molecules on the surface of outer membrane form a tight network of sugar 
molecules that use divalent cations as adducts to stabilize the outer membrane (201).  
 N. gonorrhoeae elicits a Th17 response in the mouse model of infection. Th17 
response is characterized by neutrophilia and secretion of cationic antimicrobial 
peptides (CAMP). A highly negative LOS inner core would make N. gonorrhoeae 












Figure 2.10 Role of LOS inner core charge and LOS extractability. (A and B) Computer 
simulations of the LOS layer in P. aeruginosa which show how divalent cations play a crucial 
role in improving stability by acting as adducts between neighboring LOS molecules on the 
surface (From (201)). (C) Neisserial pathogens appear to have a less negative LOS core 






Charge neutral GlcNAc instead of a negatively-charged third heptose in the LOS core 
region. My experiments with polymyxin MIC suggest that the loss of GlcNAc makes 
the bacteria more susceptible to polymyxin-mediated killing. In the commensal strain, 
the loss of the third heptose only slightly increased the polymyxin MIC. Expressing 
the RfaK protein in the N. sicca 4320 waaQ mutant strain would further help us 
understand the relationship between inner core charge distribution and TLR4 
stimulation. While this is a preliminary result, further experiments are needed to test 
if the extractability of LOS has changed. This can be tested by using BODIPY-tagged 
LOS molecules and purified human LPS-binding protein (LBP) or soluble CD14 
(sCD14). Since LOS tends to form micelles in water, the BODIPY-fluorescence is 
quenched. In the presence of LBP or sCD14, LOS is extracted from the micelles 
which makes the BODIPY tags to fluoresce. Measuring the fluorescence would help 
us understand how inner core charge distribution can affect extractability. These 
experiments are the first step towards establishing a structure-function relationship for 
the neisserial LOS inner core. Understanding the role of inner core structure in LOS-
TLR4 interaction is important for developing vaccines that can use LOS as adjuvant 




Chapter 3: Role of gonococcal surface glycosylation in 
bacteria-bacteria interaction 
3.1 Introduction 
 Gonorrhea, caused by the exclusive human pathogen N. gonorrhoeae, is a major 
public health problem. This is highlighted by the recent rise in the incidence of 
antibiotic-resistant strains prompting CDC to dub this bacterium an “immediate 
public health threat that requires urgent and aggressive action”. While laboratory 
studies on gonococci have contributed to a significant understanding of the 
mechanistic underpinnings of gonococcal interactions with the host, during natural 
infection the organism probably exists on mucosal surfaces as a biofilm (87). This 
leads to questions about the potential differences between planktonic bacteria versus 
sessile bacteria during their interaction with host cells. Studies of biofilm formation 
are also important in the context of emergence of cefixime and ceftriaxone-resistant 
strains (5).  
 Biofilm formation is important for gonorrhea pathogenesis, persistence in the 
female reproductive tract, and development of drug resistance. Biofilm formation 
begins with bacterial attachment to each other and to the surface. The bacteria then 
form a microcolony, continue to replicate and establish a mature biofilm. GC has 
been shown to form a biofilm on glass, primary and transformed human cervical 
epithelial cells (88, 118). However, little is known about how gonococci form 




gonococci disperse from the biofilm. DNA plays a critical role in organizing 
neisserial biofilm matrix with secretion of single-stranded DNA playing an important 
role in the initiation of gonococcal biofilms (80). The presence of DNase can impair 
biofilm formation and promote bacterial dispersal (118). Bacterial surface properties 
such as their hydrophobicity have also been observed to affect biofilm formation, as 
observed in N. meningitidis (114). Increased surface hydrophobicity allows the 
bacteria to aggregate and form microcolonies which seed biofilm formation. 
Similarly, the presence of polyamines such as spermine, which are present in genital 
secretions and coat the mucosal surface, also impair biofilm formation (202). These 
could also aid in bacterial escape from a biofilm, thereby promoting transmission as 
well as aiding in ascending and invasive infection. Studies on biofilms produced by 
other organisms have suggested several mechanisms of dispersal, including erosion 
(continuous release of single cells or small clusters of cells) and sloughing (rapid 
detachment of large portions of the biofilm) (110, 111). Erosion and sloughing can 
result from bacterial metabolism-associated processes, such as secretion of 
glycosidases and nucleases.  
 Gonococci in biofilms appear to be intimately associated with each other 
through unknown mechanisms. Previous work with other biofilm forming bacteria 
such as P. aeruginosa, E. coli, and S. aureus has established the role of surface 
proteins in influencing biofilm formation. Our lab had previously established the role 
of neisserial opacity-associated proteins (Opa) in causing bacterial aggregation by 
functioning as a bacterial adhesin (39). Our lab demonstrated that the lack of Opa 




epithelial cell monolayer faster than bacteria expressing Opa proteins on their surface. 
This shows that bacterial escape from microcolonies could promote invasive 
infection.  
Opa proteins can act as lectins and bind to LOS from neighboring cells (38). 
This bacteria-bacteria interaction promotes initial microcolony formation. Using 
confocal microscopy and scanning electron microscopy I have shown the importance 
of Opa in gonococcal aggregation and biofilm formation. In order to determine the 
effect of LOS truncations on biofilm formation, I compared biofilm formation 
between GC FA1090 WT strain and GC FA1090 lacking rfaK gene (which expresses 
a truncated LOS molecule lacking the terminal lactoneotetraose and GlcNAc in core 
region). Biofilm formation was markedly reduced in the presence of a truncated LOS 
molecule (see Appendix). This suggests that gonococcal biofilm formation is 
dependent on surface glycoconjugates as well as surface lectins such as Opa.  
While phase variation of Opa and LOS can modulate biofilm formation in vivo, 
the modification of glycoconjugates on the surface by glycosidases resulting in 
modulation of biofilm formation has not been clearly understood. Modification of 
surface glycoconjugates by glycosidases would also be a faster way to alter 
glycosylation than phase variation of glycosyltransferases. I hypothesized that 
modification of bacterial surface glycosylation could affect bacterial escape from 
biofilms. To see if this can happen in vivo I used bioinformatics to identify possible 
glycosylhydrolases where I identified a glucosaminidase that I characterized as NagZ. 












Figure 3.1 NagZ involved in peptidoglycan recovery in Pseudomonas spp. and E. coli. 
(A) Schematic of peptidoglycan recovery pathway from (243). NagZ is indicated by the blue 
arrow. (B) Substrate for NagZ as characterized in P. aeruginosa and E. coli. Site of cleavage 





NagZ has been established to be involved in peptidoglycan recovery in E. coli and P. 
aeruginosa (Figure 3.1). NagZ has been characterized as a exoglycosidase that 
removes the non-reducing GlcNAc residue to liberate 1,6-anhydroMurNAc peptides 
from peptidoglycan monomers (203). This is the first study to characterize the 
biochemical function of NagZ in gonococci and to identify a role for NagZ in biofilm 
modulation.  
3.2 Materials and Methods  
3.2.1 Bacterial strains and plasmids  
         N.  gonorrhoeae (FA1090, MS11, and F62) were grown in standard gonococcal 
medium (Difco, MI), designated GCP if used as phosphate-buffered broth, and 
designated GCK if used with agar, supplemented with 1% Kellogg’s supplement [48],  
at 37º C and 5% CO2.  E. coli BL21(DE3) and E.  coli DH5αMCR (Life 
Technologies, MD) were grown in L broth (LB) at 37o C or 30o C [49].  Antibiotics 
included in media were used at the following final concentrations (µg ml–1): 
ampicillin 100, kanamycin 50.  Plasmid pUC19 (New England Biolabs) and 
pET28a(+) (Novagen) were used to make deletions in various N. gonorrhoeae strains 
and to express NagZ protein, respectively.  S. aureus SH1000 strain was obtained 
from Dr. Jeffery Kaplan, George Washington University. 
3.2.2 Chemicals and Reagents 
         All reagents were purchased from Sigma-Aldrich, unless stated otherwise.  
Polymerase chain reactions were performed using Pfu polymerase (Thermo Scientific 




and carried out according to the manufacturer’s instructions.  All restriction enzymes 
were sourced from New England Biolabs (Beverly, MA).  A sample of Dispersin B 
was obtained from Dr. Jeffery Kaplan, George Washington University. 
3.2.3 Construction of mutants 
         A list of all primers used is provided in Table 3.1.  A DNA fragment carrying 
the nagZ gene of N. gonorrhoeae FA1090 along with ~850 bp of right and left 
flanking DNA sequences was amplified using primers hexoF and hexoR.  The 
resulting amplicon (~2700 bp) was cloned into the pUC19 EcoRI and HindIII sites 
and transformed into E. coli DH5αMCR, resulting in the formation of pUC19::nagZ.  
One of the isolated clones was used for further experiments.  To disrupt nagZ in the 
gonococcus, a Kanamycin (Kan) resistance gene was excised from pK18 with SmaI,  
the DNA fragment purified from agarose gel and inserted into the EcoRV site of 
pUC19::nagZ.  A plasmid from a presumptive E. coli clone carrying 
pUC19::nagZ::Kan was isolated and the construct was verified by DNA sequencing 
(Macrogen, USA).  This plasmid DNA was cleaved with EcoRV and ligated with 
double-strand oligo DNA prepared from DUSF and DUSR, which contain two 
EcoRV sites and N. gonorrhoeae DNA uptake sequence, after cleaving with EcoRV.  
Kanamycin resistant transformants were selected, the plasmid DNA isolated and 
checked for the presence of the uptake sequence.  Plasmid DNA from such clones 
was used for transformation of N. gonorrhoeae strains by liquid transformation 
method and selected on GCK plates containing kanamycin (50 µg/ml). nagZ was 
deleted by a spot transformation technique in N. gonorrhoeae FA1090, N. 




























3.2.4 Expression and purification of NagZ protein 
         A DNA fragment encoding nagZ isolated from N.  gonorrhoeae FA1090 was 
amplified using primers Ngo0135F and Ngo0135R and the resulting amplicon (1300 
bp) was cloned into pET28a(+) using NheI and XhoI, resulting in the formation of 
plasmids pET28a(+)::nagZ.  To purify NagZ, a single colony generated by 
transformation of E. coli BL21(DE3) with pET28a(+)::nagZ was used to inoculate 
100 ml of LB broth with kanamycin.  Cultures were incubated at 37 oC, and when the 
OD600 of the culture reached 0.6, IPTG was added to a final concentration of 1 mM.  
Incubation was continued at 30 oC for an additional 12 hr.  Cultures were centrifuged 
and bacterial pellets were resuspended in 10 ml buffer A containing 50 mM NaH2PO4 
(pH 8.0), 300 mM NaCl, 20 mM imidazole, 10 mM -mercaptoethanol, 0.1% (v/v) 
Tween 20, 100 µM PMSF.  After sonication, the cellular debris was removed by 
centrifugation at 40 000 g for 1 hr and then the supernatant applied to a 3 ml Ni-NTA 
agarose column previously equilibrated with 100 ml of above buffer.  The column 
was washed with 100 ml of buffer B containing 50 mM NaH2PO4, 300 mM NaCl, 20 
mM imidazole and 10% (v/v) glycerol and the proteins eluted with a 6 ml of buffer B 
containing increased concentration of imidazole (20 mM, 50 mM, 100 mM, 150 mM, 
200 mM and 250 mM).  N-acetyl-β-D-hexaminidase eluted at 150 mM -200 mM.  
The fractions containing the purified proteins were pooled and dialyzed against buffer 
B and reapplied to a Ni-NTA agarose column.  The purity of the enzyme was 
determined by running an aliquot on a 15% SDS-PAGE.  PageRulerTM prestained 
protein ladder (170, 130, 100, 70, 55, 40, 35, 25, 15 and 10 kDa) (Fermentas) was 




3.2.5 LOS purification and analysis 
         LOS was purified from broth-grown cells by hot phenol-water method (204).  
LOS was then concentrated by lyophilization and extraction with hot phenol-water 
continued until the preparation obtained minimal absorbance at 200nm.  LOS was 
analyzed on a 16.5% Tris-Tricine gel at a fixed current of 0.03 mA in an ice-cooled 
chamber, and visualized by silver staining (196). 
3.2.6 Hexosaminidase assay 
         Enzyme activity was assayed using various p-nitrophenol tagged saccharides as 
substrate.  The standard reaction mixture consisted of 20 µl of substrate solution at a 
final concentration of 1.2 mM, 20 µl of 1 M KPO4 buffer pH 8.0 (final concentration 
of 200 mM), 50 µl of water and 2 µg of enzyme (final concentration of 380 nM).  
After 30 min incubation at 37o C, the reaction was stopped by addition of 50 µl of 200 
mM glycine NaOH buffer pH 10.  Water (860 µl) was then added and the release of 
p-nitrophenol from the substrate was monitored at 405 nm.  One unit (U) of enzyme 
was defined as the amount of enzyme that released 1 µmol of p-nitrophenol from 
pNP-GlcNAc per min at 37 o C. 
3.2.7 Biofilm formation  
         To prepare biofilms, bacteria from overnight cultures grown on GCK agar 
plates were suspended in GCP with sodium bicarbonate and Kellogg’s supplement to 
a final concentration of 108 bacteria per mL.  Dynamic biofilms were grown in new 
heat-sterilized glass tubes by adding 1 mL of the bacterial suspension per tube, and 




suspension of bacteria to a Klett of 100 in GCP and adding an aliquot to culture plates 
using published methods (114). The biofilms were then quantitated by staining with 
1% w/v crystal violet. The crystal violet stained biofilm was eluted out by dissolving 
in 30% acetic acid and the absorbance read at 590 nm in a spectrophotometer.  
3.2.8 Confocal Microscopy analysis  
         Static biofilms were grown in 35 mm glass bottom microwell dish with No. 15 
coverglass (MatTek, MA) for 48 hr (114).  Biofilms were washed with PBS three 
times and stained with Hoechst stain or propium iodide as appropriate for 15 min 
fixed with 4% PFA for 20 min visualized with Leica TCS SP5 X confocal microscope 
(Leica Microsystems, IL, USA).   
3.2.9 Scanning electron microscopy  
         Static biofilms were grown for 36 hr over a glass coverslip placed inside a 24-
well cell culture plate.  Briefly, the coverslips were gently washed three times with 
PBS, and fixed with 2% glutaraldehyde for 60 min at RT and then overnight at 4o C.  
The coverslips were fixed the next day using 1% osmium tetroxide, dehydrated by a 
series of washes with increasing concentrations of ethanol, dried by critical point 
drying method, and finally coated with gold-palladium alloy (205).  Samples were 
visualized with Amray 1820D microscope (20 kV) and/or Hitachi S4700 microscope 
(5 kV).  
3.2.10 Statistical analysis:  
         Experiments were repeated as three independent trials and data analysed using 




determined by Student’s t-test unless specified (Graphpad Prism 6). Error bars shown 
are standard errors of mean, unless specified otherwise.      
3.3 Results 
3.3.1 Identification of putative glycosylhydrolases in the neisserial genome  
 I performed a bioinformatic screen on N. gonorrhoeae genomic DNA 
sequences using the glycosylhydrolase library in Carbohydrate-Active enZYmes 
database (CAZY) and created a list of putative glycosidases, listed in Table 3.2, 
which also shows the accession number for the corresponding protein in NCBI and 
the glycosylhydrolase family number. The majority of them were annotated in NCBI 
as enzymes involved in the peptidoglycan recovery pathway. I focused on ORF0135 
because it encoded a putative hexosaminidase. Since the terminal sugar in LOS is a 
hexosamine, I hypothesized that ORF0135 could be able to act upon LOS and 
truncate the outer core. In addition, Apicella et al showed the presence of hexosamine 
in neisserial biofilm using lectin-binding studies, which suggested that hexosamines 
play a critical role in bacterial aggregation (88). ORF0135 was also present in all the 
neisserial genomes available on NCBI, including commensal species which suggests 
an essential role for the enzyme. 
3.3.2 ORF0135 encodes a cytoplasmic hexosaminidase  
 Using the CAZY database, I determined that ORF0135 in N. gonorrhoeae 
FA1090 encoded a putative beta-hexosaminidase (EC 3.2.1.52) belonging to glycosyl 




non-reducing N-acetyl-D-hexosamine residues using retaining hydrolysis mechanism. 
To identify the protein localization I analyzed the protein sequence using the web-
based protein analytical software MESSA (MEta Server for Sequence Analysis) 
(206). MESSA is an integrated tool that uses multiple other tools such as PSIPRED 
(for secondary structure prediction), DISEMBL (for predicting coils and loops), and 
TOPRED (for transmembrane helix identification) to determine the protein structure, 
location and function for a given protein sequence. I predicted that ORF0135 is a 
cytoplasmic protein with hexosamindase activity. Figure 3.2 shows a sequence logo 
representation of the active site for GH3 family of hexosaminidases.  
 The consensus pattern is [LIVM](2)-[KR]-x-[EQKRD]-x(4)-G-[LIVMFTC]-
[LIVT]-[LIVMF]-[ST]-D-x(2)-[SGADNIT], where D is the active site residue. The 
top panel in figure 3.3 shows the synteny of orf0135 in N. gonorrhoeae FA 1090. The 
synteny was identical in all the gonococcal genomes available, but varied in 
commensal neisserial species. Comparison of ORF0135 protein from all other 
neisserial species showed that the protein is present in all neisserial species and 
highly conserved as shown in the panel A of figure 3.3, where height of the green 
bars corresponds to degree of identity at the nucleotide level among all sequenced 
gonococcal genomes. I propose renaming orf0135 as nagZ because of the high 
sequence similarity with nagZ gene in other gram-negative bacteria. This is shown in 
panel B of figure 3.3, comparing the NagZ protein sequence in N. gonorrhoeae, E. 
coli, and P. aeruginosa. The purple arrow in the C-terminal half of the protein shows 











Table 3.2 List of putative glycosylhydrolases in N. gonorrhoeae FA 1090 The accession 
number for the corresponding protein, from NCBI and the glycosylhydrolase 





3.3.3 Biochemical characterization of NagZ  
 Using PCR amplification, a fragment of DNA encoding nagZ was cloned into 
the expression vector pET28a, transformed into E. coli BL21(DE3), and the 
expression of nagZ was induced with IPTG. After purification on a nickel column, an 
aliquot of the protein was analyzed by SDS-PAGE. The molecular mass of NagZ as 
determined by SDS-PAGE (47 kDa) was consistent with the predicted mass for this 
protein (Figure 3.4 Panel A). I determined the optimal enzymatic conditions for NagZ 
using p-Nitrophenyl N-acetyl-β-D-glucosaminide as substrate. The purified enzyme 
showed no dependence on divalent ions. The enzyme showed highest activity at 200 
to 400 mM of potassium phosphate buffer. The optimal conditions were determined 
to be 37ºC, in potassium phosphate buffer (200 to 400 mM) at a pH of 8.0 (Panels B 
and C, Figure 3.4). The enzyme retained activity even after 48 hours incubation at 
room temperature. The kinetic parameters Km and Vmax against pNP-GlcNAc were 
determined as 3.2 mM and 64 µmol min-1 mg-1 respectively. These values are in the 
same order of magnitude as those for several other hexosaminidases. I further 
screened for activity of this enzyme using pNP conjugated to a variety of other sugar 
moieties as listed in figure 3.3, panel D. Of the substrates that produced detectable 
cleavage products, NagZ had maximal activity on p-Nitrophenyl N-acetyl-β-D-
glucosaminide. I also observed some activity against β-D-N’,N-bisacetylchitobiose. 
There was negligible activity against α- and β-forms of both glucopyranoside and 
galactopyranoside, as well as against acetylated forms of galactosaminide. This 
suggests that NagZ is predominantly an exoglycosidase but also has some 


















Figure 3.2 Sequence logo of the consensus sequence type 3 glycosylhydrolases. The active 
site sequence was extracted from all the known glycosylhydrolase (GH3) type 3 proteins in the 
CAZy database and aligned. The most abundant amino acid residue(s) at each position are 
shown. The height of the amino acid at each position corresponds to their relative frequency 
among the sequences compared. The D at 15th position is the active residue. The consensus 
pattern corresponds to [LIVM](2)-[KR]-x-[EQKRD]-x(4)-G-[LIVMFTC]-[LIVT]-[LIVMF]-









Figure 3.3 Bioinformatic analysis of nagZ gene. (A) Nucleotide alignment and genomic 
organization of nagZ in gonococcal genomes ( NC_002946.2, NC_011035.1, 
ABZF01000028.1, ABZG01000030.1, ABZH01000027.1, ABZI01000026.1, 
ABZL01000026.1, ABZM01000035.1, ABZN01000023.1, ABZO01000044.1, 
ABZP01000042.1, ABZQ01000043.1, ACIG01000102.1, ADAA01000005.1, NC_017511.1, 
AKCG01000001.1, AKCH01000001.1, ABZJ02000001.1, and NC_022240.1). The height of 
green bars correspond to degree of identity among the different strains. (B) Amino acid 
alignment of NagZ protein sequence from N. gonorrhoeae, E. coli and P. aeruginosa. The 
position of GH3 family active site and dyad site are highlighted. Gonococcal NagZ is 39% 
identical and 55% similar to E. coli NagZ, and 41% identical and 56% similar to P. 
aeruginosa NagZ. The tall green bars represent identical amino acids, and smaller yellow 







 To determine if NagZ can act as a β-1,6-hexosaminidase, I used Staphylococcus 
aureus strain that produces an extracellular polymeric substance (EPS) predominantly 
composed of poly β-1,6-N-acetyl-glucosamine (PNAG). I used dispersin B, which is 
a β-1,6-hexosaminidase as a positive control. The biofilm was stained after washing 
with crystal violet and quantified as described in the methods section. Figure 3.4 
(Panel E) shows the comparison of biofilm without and with enzymatic treatment. 
NagZ treatment had a very slight reduction on S. aureus biofilm, whereas dispersin B 
dramatically reduced the biomass of the bioiflm. Dispersin B treatment of gonococcal 
biofilm also had a negligible impact on its biofilm, showing that gonococcal biofilm 
is not composed of significant amounts of PNAG. I conclude, from these data, that 
NagZ lacked endo-β-1,6-hexosaminidase activity. Since even prolonged treatment 
with NagZ had no impact on the S. aureus biofilm, I conclude that NagZ lacks exo-β-
1,6-hexosaminidase activity. 
3.3.4 NagZ is not secreted and it is not essential  
 Because NagZ is needed for recovery of monosaccharides from the PG 
monomers released during the cytosolic steps of the muropeptide-recycling pathway 
in E. coli, I made a NagZ knockout to see if NagZ is essential for survival to see if the 
accumulating PG fragments affect gonococcal viability. I constructed a NagZ deletion 
strain by transforming pili-positive wild type strain of N. gonorrhoeae with a DNA 
fragment constructed to contain a kanamycin cassette instead of nagZ gene, and 
selected for kanamycin-resistance transformants. The deletion was verified by DNA 
sequence analysis after PCR amplification of the region containing the deletion. I also 






















Figure 3.4 Biochemical analysis of NagZ. (A) SDS-PAGE gel of purified NagZ.  Lane 1 is 
the molecular weight standard (mass of each band is indicated on the left of the gel, in kDa) 
and lane 2 is purified NagZ.  (B) The activity profile for NagZ as assayed over a variety of 
temperatures. (C) The activity profile for NagZ as assayed over a variety of pHs.  For panels 
B and C, the activity of NagZ used p-Nitrophenyl N-acetyl-β(1-4)-D-glucosaminide as a 
substrate.  (D) The relative activity of NagZ for various substrates measured at 37ºC at a pH 
8.0.  (E) Biofilm of S. aureus SH1000 was incubated with Dispersin B (10 µg) or NagZ (20 
µg), and the amount of biofilm remaining in the well determined by measuring the biomass.  
Data represents mean values (± SE) of three independent experiments performed in triplicate.  
Statistical significance was determined using two-tailed t-test assuming unequal variance. (n 
























Figure 3.5 Cleavage of pNP-GlcNAc by NagZ. A cartoon representation of cleavage of 4-
nitrophenyl N-acetyl-B-D-glucosaminide by NagZ releasing free N-acetyl glucosamine and 





the growth rate of the wild type strain as shown in panel A of figure 3.6. NagZ is not 
essential for GC survival as I was able to make the mutant. 
  To see if NagZ is secreted, GC were grown to mid-log phase and bacterial 
growth media was collected to separate supernatant and bacterial pellet. After lysing 
the bacterial pellet, I tested for NagZ activity in both the bacterial lysate as well as the 
supernatant. I did not detect NagZ activity in the supernatant, unlike bacterial pellet 
as shown in panel B of figure 3.6. This suggests that NagZ is not secreted by the 
bacteria, as predicted by MESSA analysis. NagZ protein is not a secreted protein in 
other bacterial as well (207).   
3.3.5 NagZ is present extracellularly   
 Gonococci express an autolysin atlA, which encodes a peptidoglycan hydrolase. 
Dillard and Seifert have shown that AtlA is responsible for bacterial lysis seen during 
stationary phase (208). I hypothesized that even though NagZ is predicted to be a 
cytoplasmic enzyme, I should be able detect the presence of NagZ activity in the 
supernatant after GC start lysing during the stationary phase. Bacteria were grown in 
broth, and aliquots of the culture supernatant tested for NagZ activity at various time 
points. Panel A in figure 3.6 shows the relative levels of NagZ activity at various time 
points in the supernatant and bacterial lysate, in comparison with the growth curve. I 
also tested the nagZ deletion strain for NagZ activity. There was no detectable 
activity in the deletion strain, confirming that the gene has been knocked out and that 
there are no other hexosaminidases present in N. gonorrhoeae FA 1090 (Panel B 
Figure 3.6). Figure 3.6 shows that NagZ activity begins to increase as the culture 








Figure 3.6 NagZ is found in culture supernatants of stationary phase grown 
gonococci.  (A) Growth of FA1090 and FA1090 ΔnagZ was monitored hourly by measuring 
the turbidity using a Klett-Summerson colorimeter.  Liquid broth (1 ml) was collected every 2 
hours and assayed for presence of NagZ, using the methods described in the materials and 
methods. (B) Broth from a 6 hour culture of FA1090 and FA1090 ΔnagZ was spun down and 
NagZ activity was tested as described in methods section by running the reaction for 1 hour 





activity in the supernatant corresponded to the reduction in bacterial viability. 
3.3.6. nagZ knockout strain forms thicker biofilm   
 Gonococcal strains growing in biofilms are under significant metabolic stress. 
Since I have shown in the previous experiments that NagZ can be detected in the 
extracellular milieu after stationary phase, I further hypothesized that the extracellular 
NagZ could play a role in modulating interaction between individual bacteria and 
hence affect biofilm formation. To test this hypothesize, I compared the wild type and 
nagZ knockout strains of N. gonorrhoeae (FA 1090, MS11, and F62) for biofilm 
formation. Since presence of pili increases biofilm formation by promoting bacterial 
aggregation I used non-piliated bacteria for all my experiments in order to eliminate 
the effect of pili-mediated aggregation.  
 The biofilms were formed under both static and dynamic conditions. Static 
biofilms were formed by incubating bacteria in GCP with Kellogg’s supplement in 
24-well tissue culture plates in an incubator, and dynamic biofilms were developed at 
the liquid-air interface on the inner surface of culture tubes placed in a rotary shaker 
at 37º C. After 48 hours, the supernatant media along with planktonic bacteria was 
aspirated and the biofilm washed three times and allowed to dry. Biofilm formation 
was measured by staining with crystal violet, removing the biomass from the glass 
surface by washing with acetic acid, and measuring the absorbance at 590 nm.  Figure 
3.7 shows an example of dynamic biofilm formed by the two different strains after 48 
hours (Panel A). The biofilms were quantitated and shown in panel B figure 3.7. I 
observed that there was a significant increase in the biofilm formation by the nagZ 




three strains of GC used in this experiment.  
 Because the greatest difference was seen in N. gonorrhoeae FA 1090 strain 
compared to other gonococcal strains, I used FA 1090 for most of the experiments on 
biofilm formation. N. gonorrhoeae FA1090 also served as a better model to study the 
role of surface sugar in biofilm formation since it does not contain Type IV secretion 
system encoded in a 57-kb region labeled gonococcal genomic island (GGI) (75). This 
precludes confounding by secreted DNA affecting biofilm formation. I also 
complemented the ΔnagZ strain by reintroducing nagZ into the mutant. Biofilm made 
by the complemented strain was compared with both wildtype and the mutant strain 
as shown in figure 3.7 panel B. It can be seen that complementation restores the 
original wildtype phenotype in the mutant and forms less biofilm. 
3.3.7 Biofilm evolution over time  
 In order to understand how the two biofilms evolve over time the biofilm levels 
were measured at various time points. The biofilm formed by wildtype and nagZ 
mutant strains were compared at each time point as shown in figure 3.8. The 
corresponding static biofilms were also imaged using SEM (Figure 3.9). I found that 
while the biofilm formation between the two strains was not significantly different at 
6 hrs after incubation, the mutant strain started forming a thicker biofilm after the 12 
hr time point. The biofilm formed by the mutant strain kept increasing in quantity 
until 72 hrs whereas the wildtype biofilm increased until 24 hrs, plateaued at 48 hrs, 
and even slightly degraded at 72 hrs. This could be possible because bacterial lysis-
















Figure 3.7 Biofilm formation by gonococcal strains. (A) Photograph of dynamic biofilm 
formed by wildtype bacteria (left) and the ΔnagZ mutant strain (right) after 24 hrs.  (B) 
Quantification of dynamic biofilm formation by FA 1090 wildtype and FA 1090 ΔnagZ on 
the left (n = 6) and static biofilm formed by the same strains on the right, using crystal violet 
staining and measuring absorbance to estimate relative biomass as described in the methods.  
Complementation of nagZ in the knock out strain reduced the ability of the mutant to form a 



















Figure 3.8 Biofilm evolution over time by wildtype and ΔnagZ strains. (A) Dynamic biofilms 
were prepared, and the biomass of biofilm determined at various time points by crystal violet 
staining method as described in the methods section. Statistics were analyzed by two-tailed t-test 









Figure 3.9 SEM of gonococcal biofilm. Static biofilm by N. gonorrhoeae FA 1090 WT and  






promoting biofilm degradation, possibly also in association with release of other 
intracellular biofilm degrading agents such as nuclease. The absence of NagZ could 
explain the continuously increasing biofilm being formed the deletion strain. Since 
the growth curve of the two strains looks identical it is unlikely that a defect in 
bacterial survival could be the cause for increased biofilm formation.  
3.3.8 Visualization of the biofilm  
 In order to understand the biofilm architecture, I used microscopic techniques to 
visualize the biofilm formed by the two strains. I used confocal microscopy on the 
static biofilms grown for 36 hours, using Hoechst stain to visualize the biofilm. The 
biofilms were grown in MaTeK glass bottom dishes. The mutant strain formed a 
denser and taller biofilm (~4 fold increase), consistent with qualification of biomass 
using crystal violet method, as shown in figure 3.10. In addition I also observed that 
the wildtype biofilm has bacteria escaping the biofilm in small clusters while this is 
seldom seen in the mutant biofilm. This suggests a defect in bacterial dispersal from 
biofilm caused by nagZ deletion.  
 In order to see if there was an alteration in bacterial survival in the biofilm, I 
stained the biofilm with Hoechst and propidium iodide (PI) to analyze the proportion 
of live and dead bacteria in the biofilm. Hoechst stains both dead and live bacteria 
whereas PI only permeates the membranes of dead bacteria. The data in figure 3.11. 
shows the double-stained biofilms visualized by confocal microscopy. Panel B shows 
quantification by comparing the mean fluorescence intensity ratio (FIR) of Hoechst 




in both kinds of biofilm, although the amount of dead bacteria increased over time as 
seen by an increase of fluorescence intensity of PI. 
 I visualized the surface of the biofilm using a SEM. Figure 3.9 shows the 
biofilm formation over a glass slide visualized at various time points. The SEM image 
shows a very similar-looking biofilm at 6 hour in both strains whereas the wildtype 
strain appears to form sites of enucleation at 12 hours in contrast to the mutant which 
is spread out and begins forming a diffuse biofilm. The nagZ knockout strains forms a 
denser biofilm and continues to increase in density until 48 hours and shows a slight 
degradation whereas the wildtype biofilm begins to start degrading after 48 hours. 
Analysis of older biofilms suggested that FA 1090 was lysing, releasing intracellular 
contents such as DNase. This was evident by reduced amount of DNA visible in the 
older FA 1090 biofilms as compared to FA 1090 ΔnagZ biofilms. 
 Since all of the previous experiments were carried out on abiotic surfaces, I 
tried to understand biofilm formation on biotic surface using both human cell lines 
and human cervical tissue explants. Cervical tissues were obtained from consenting 
women undergoing uterine surgeries and sourced by NDRI. The tissue was cut into 
small pieces of endocervical tissue and ectocervical tissue, and grown in CMRL 
media in 24-well plates. Each piece of tissue was approximately 3 millimeter by 3 
millimeter. The tissue was infected with approximately 109 bacteria per tissue piece, 
with both wildtype and mutant strain for various times. Map tiling function was used 

















Figure 3.10 Confocal imagine of biofilm formation by gonococcal strains. Static biofilm 
formed by N. gonorrhoeae FA 1090 wildtype (left) and N. gonorrhoeae FA 1090 ΔnagZ 
(right) visualized by confocal microscopy, after staining with Hoescht. The view on top 
shows a tilted x-y projection and view on bottom is x-z representation of the same biofilm 






     
  
 
   
   
   
   
   
   






























































































































































































































































tiled using automated software to create a Z-stack of the entire cervix specimen. The 
stacks were Z-projected as shown in figure 3.12. Confocal imaging showed that the 
mutant strains were able to form a better biofilm on the surface of cervical tissue than 
the wildtype strain (Figure 3.12). I used ImageJ to quantify the fluorescence intensity 
in proportion to the area of tissue as well as the ratio of biofilm fluorescence intensity 
to fluorescence intensity of Hoescht staining since it should be representation of the 
total number of cells in the tissue slice. I observed that the proportions in both 
measures were higher in the nagZ experiment compared to wildtype strain, which is 
in agreement with experiments performed abiotic surface (Figure 3.10). Biofilms 
formed over cervical tissue explant were also visualized by SEM. The data in figure 
3.14 shows biofilms formed by both strains over cervical explants. Similar to 
previous experiments on glass surface, I observed that the mutant strain forms a 
denser biofilm over cervical explants as evident by the increase in bacterial density as 
well as cervical epithelial cell damage. The experiments were performed by forming 
biofilm for 48 hours on the surface of cervical tissue explants. Figure 3.15 also shows 
biofilm formation by the two strains on the apical surface of polarized T84 cells, 
which is a colonic epithelial cell line. The biofilm formation above the apical surface 
was marked out using ImageJ (the gaps within biofilm were excluded) and the 
proportion of biofilm area to tissue area was calculated using 2500x images taken 
from random fields. Figure 3.16 shows the comparison of the quantification of 
biofilms formed by wildtype and ΔnagZ strains. This data is consistent with our 













Figure 3.12 Gonococcal biofilm formation on cervical explant tissue. Biofilm formed on 
the surface of human cervix tissue explant by N. gonorrhoeae FA 1090 WT (on top row) and 
N. gonorrhoeae FA 1090 ΔnagZ (on bottom row) was fixed after 48 hours and visualized by 
confocal microscopy. The tissue was stained for nucleus (Hoechst - blue), actin (phalloidin - 
green), and gonococci (anti-GC antibody - red). The right most panel shows an overlay of all 














Figure 3.13 Quantification of gonococcal biofilm formation on cervical explant tissue. 
Normalized ratio of mean fluorescence intensity (MFI) of gonococcal biofilm to tissue 
surface area determined by ImageJ for FA 1090 wildtype and FA 1090 ΔnagZ strain. Results 













Figure 3.14 SEM of gonococcal biofilm on cervical explant tissue. (A) SEM images 
showing biofilm formation (after 96 hours) by wildtype and ΔnagZ strains of N. 
gonorrhoeae FA1090 on the surface of human cervix tissue along with uninfected cervix 
sample on the left side, at 250x and 2500x. Red arrow shows squamous epithelial cells that 
are being sloughed off and yellow arrow points at cuboidal cells in bottom layer that are now 
exposed. (B) Cartoon representation of stratified squamous epithelial layer in uninfected 
sample and epithelial shedding seen in infected samples.  
  
 
       





        











Figure 3.15 SEM of gonococcal biofilm on polarized T84 cells. Gonococcal biofilm was 
formed on the apical surface of polarized T84 epithelial cells by N. gonorrhoeae FA 1090 
WT and ΔnagZ strains at 6 hours and 24 hours. Images taken at two different magnification 
(1000x and 2500x) are shown for each biofilm. The left most images are taken from 
uninfected T84 epithelial cells. Green arrows point to apical surface of epithelial cells and red 




















Figure 3.16 Quantification of gonococcal biofilm on epithelial cells. SEM images were 
taken at random fields at 2500x magnification and the area of epithelial cell surface covered 
by biofilm measured manually using ImageJ. The ratio of area covered by biofilm to the total 
area of the image was calculated for both wildtype and ΔnagZ strains. Two-tailed Student’s t-





3.3.9 nagZ deletion does not alter blebbing  
 N. gonorrhoeae generates outer membrane vesicles. Alterations in vesicle 
formation has been observed in bacteria with defects in peptidoglycan metabolism, 
membrane protein synthesis and the σE envelope stress response (209). Since NagZ is 
involved in peptidoglycan recycling, it is possible that NagZ could affect biofilm 
formation indirectly by increasing the release of outer membrane vesicles (210). To 
determine if deletion of nagZ resulted in a change in the ultrastructure of bacteria in 
biofilm, high resolution scanning electron microscopy (SEM) was used to visualize 
the biofilm architecture and the ultrastructure of bacteria within the biofilm. SEM can 
also be used to identify any defects in EPS matrix components which could explain 
the difference in biofilm formation between the two strains. Biofilms were grown as 
described earlier, under static conditions and samples fixed for SEM microscopy. 
Figure 3.17 shows membrane blebbing on the surface of individual bacteria in both 
wild type and knockout strains at all time points.  
 I measured the distribution of membrane blebs using ImageJ. Images of random 
fields were taken at 20000x magnification and blebs were identified by defining their 
size as less than 250 nm (210). Figure 3.18 shows that there was no difference in bleb 
distribution between the two strains, which rules out membrane blebbing defect as 
cause for difference in biofilm formation. SEM images also show what appears to be 
DNA entangling the bacterial aggregates in a random fashion. The source of DNA is 
possible bacterial lysis since the strain I used (FA 1090) does not secrete DNA, unlike 
MS11 or other strains possessing the GGI. The DNA strands were disappeared after 









Figure 3.17 High resolution SEM of gonococcal biofilm. High magnification image of 
gonococcal clusters found within the biofilm at different time points in wildtype and 
ΔnagZ strains (20,000x).  These images are representative of bacteria when they are 

















Figure 3.18 Quantification of blebbing. Average number of OMV blebs per field in 
biofilm formed by wildtype and ΔnagZ strain. Multiple SEM images of 48 hour biofilm 
were taken at 20000x magnification of wildtype and ΔnagZ strains. Membrane blebs were 






suggesting they are composed of nucleic acid. The presence of DNA, in spite of the 
absence of a known secretion system, shows that intracellular contents are released 
following bacterial death and that bacterial lysis serves a vital purposes in biofilm 
formation. I did not observe any differences in extracellular DNA (eDNA) or 
membrane blebbing in either strain, showing that the differences in biofilm formation 
are not due to any alteration in vesiculation or eDNA availability. 
3.3.10 DNA contributes to structural integrity of both WT and mutant 
biofilm 
 Zweig M et al have shown that secreted single-stranded DNA (ssDNA) plays a 
role in the initial phases of biofilm formation, but it is not incorporated in mature 
biofilms in N. gonorrhoeae MS11 (80). To understand the role of eDNA in biofilm 
stability in N. gonorrhoeae FA1090, which releases eDNA predominantly by lysis, I 
measured the amount of biofilm formed in the presence of DNase at varying time 
points by both wildtype and mutant strains. The biofilms were stained and measured 
the same way as described before. Figure 3.19 shows that both wildtype and mutant 
strains appear to be equally affected by presence of DNase with regard to biofilm 
formation. Further, there was no difference in effect of DNase co-incubation between 
biofilms formed at 24 hours, 48 hours, and 72 hours, suggesting that eDNA in GC 
FA1090 biofilm plays a structural role both in early biofilm and mature biofilm. This 
experiment highlights the vital role played by eDNA in GC biofilm. 
3.3.11 Biofilm dispersal by adding exogenous NagZ  
















Figure 3.19 Role of DNA in gonococcal biofilm. Absorbance of biofilm formed by wildtype 
and ΔnagZ strains, with and without DNase incubation, measured at 590 nm after staining 
with crystal violet as described in methods. Data represents mean values (± SEM) of three 
independent experiments performed in triplicate.  Statistics were analyzed by two tailed 
Student’s t-test (*** p < 0.001). 
 




biofilm dispersal, I added purified NagZ on biofilm formed by gonococci. Static 
biofilms were formed and treated with NagZ protein for 3 hrs at 37ºC. Biofilms were 
either quantified by crystal violet method or visualized by SEM, after treatment.  
 The data in Figure 3.20 shows that NagZ treatment reduces the thickness and 
density of biofilm formed by the mutant, making its appearance more reminiscent of 
the biofilm formed by wildtype strain. NagZ-treated biofilms still show presence of 
intact strands of genetic material which disappeared on treating with DNase. 
Although NagZ is not a secreted protein, it can have a direct effect on biofilm 
formation through extracellular release following autolysis, along with other 
intracellular contents that can potentially modulate biofilm formation such as the Nuc 
thermonuclease. Our experiments showing NagZ activity in the supernatant 
(stationary phase) of broth culture but not in mid-log phase supernatant support this 
idea. 
3.3.12 NagZ does not act upon LOS  
 Previous work from our lab and other labs has shown the importance of LOS in 
bacteria-bacteria interaction. Deletion of rfaK in N. gonorrhoeae FA 1090, which 
results in loss of lactoneotetraose as well as the GlcNAc in the LOS core region, 
results in significantly impaired biofilm formation. Since it appears that exogenously 
added NagZ can impair biofilm formation, I wanted to investigate if NagZ can act 
upon LOS. In addition, NagZ was able to cleave a variety of substrates containing N-
acetylglucosamine, and neisserial LOS contains N-acetylglucosamine in a variety of 
conformations. LOS was purified from N. gonorrhoeae F62 using hot phenol-water 
















Figure 3.20 Biofilm destruction by exogenously added NagZ.  (A) SEM showing 
differences between untreated ΔnagZ biofilm (first column), ΔnagZ biofilm treated 
with NagZ (second column), and ΔnagZ biofilm treated with DNAse (third column) 
at 250x and 5000x magnifications. The DNA strands disappear on treatment with 
DNAse in the third column, while NagZ almost completely destroys biofilm.  (B) 
Quantification of biofilm formed by untreated mutant strain, and mutant strain 
biofilm treated with purified NagZ, using crystal violet method.  There is a 
statistically significant reduction in biofilm on treatment with NagZ (**p < 0.01).  














of undigested LOS. Panel A in figure 3.21 shows the 16.5% Tris-tricine gel, silver-
stained, where lane 1 and 2 are control lanes of N. gonorrhoeae F62 Δ8-1 and N. 
gonorrhoeae F62 wildtype strain respectively. The structures corresponding to each 
band in the gel are marked as A, B or C and are represented in the bottom panel. Lane 
3 shows LOS from N. gonorrhoeae F62 ΔnagZ which does not show any difference 
in comparison to lane 3 and 4. Lane 4 is the same LOS as in lane 3 but treated with 
purified NagZ in vitro. Since lanes 2, 3 and 4 are virtually identical, I concluded that 
NagZ does not act upon LOS even though there are terminal and internal GlcNAc 
molecules in various forms. This showed that NagZ lacks β-1-3 exoglycosidase 
activity and α-1-2 endoglycosidase activity.  
3.3.13 NagZ acts on peptidoglycan  
 NagZ in other organisms such as E. coli and P. aeruginosa function in 
peptidoglycan recovery by cleaving GlcNAc from PG monomers. NagZ was tested 
for its ability to digest peptidoglycan fragments in the extracellular milieu. As 
gonococci grow they recycle most of the peptidoglycan fragments removed from the 
sacculus, but they release a significant portion of these fragments into the medium. 
Our collaborators at University of Wisconsin, Jonathan Lenz and Joe Dillard carried 
out the following experiment. N.gonorrhoeae was pulse-labeled with [6-
3H]glucosamine to label the N-acetyl glucosamine and N-acetylmuramic acid in 
peptidoglycan in the cell wall. After a 2.5 hr chase period, the supernatant was 
collected and the ability of purified NagZ to digest peptidoglycan fragments in the 
supernatant was examined. The addition of boiled NagZ had no apparent effect on the 












Figure 3.21 NagZ does not act upon gonococcal LOS. (A) SDS-PAGE gel of LOS isolated 
from: 1) N.  gonorrhoeae F62 Δ8-1; 2) N. gonorrhoeae F62; 3) N. gonorrhoeae F62ΔnagZ; 
and 4) N. gonorrhoeae F62ΔnagZ  treated with NagZ. (B) Graphical representation of the 
oligosaccharide portion of LOS isolated from F62.  Letters in the LOS schematic correspond 











Figure 3.22 NagZ acts on peptidoglycan monomers. Gonococci were metabolically labeled    
with [6-3H]glucosamine.  After a chase period, supernatants were collected and treated with 
purified NagZ.  Radiolabeled fragments were separated by size exclusion chromatography and 
detected by liquid scintillation counting.  Gonococcal peptidoglycan contains PG dimers, 
monomers, free disaccharide, and anhydro-N-acetylmuramic acid.  GlcNAc, N-
acetylglucosamine; MurNAc, N-acetylmuramic acid; anhMurNAc, anhydro-N-acetylmuramic 





fragments showed the presence of dimers, monomers, and free disaccharide as has 
been observed in multiple studies of peptidoglycan fragment release from gonococci 
(Figure 3.22). Addition of active NagZ changed the profile of peptidoglycan 
fragments.  The peptidoglycan monomer peak shifted to later fractions (smaller size) 
from the sizing columns, consistent with the removal of N-acetyl glucosamine from 
the peptidoglycan monomers.  Similarly, the free disaccharide peak was eliminated 
and a peak appeared for free 1,6-anhydro-N-acetylmuramic acid.  No significant 
changes were seen to the peaks for peptidoglycan dimers and tetrasaccharide-peptide, 
suggesting that these molecules are not substrates of NagZ.  These data are consistent 
with the known activity NagZ in other bacteria, acting to remove N-
acetylglucosamine from peptidoglycan monomers and free disaccharide. In addition, 
adding NagZ to live bacteria had no effect on their viability unlike lysozyme which 
has endoglucosaminidase activity. This further confirmed that NagZ lacked 
endoglycosidase activity.  
3.3.14 NagZ-mediated biofilm degradation is affected by surface 
glycosylation 
 Goodwin et al in a recent paper demonstrated how E. coli sabotages production 
of O-linked-GlcNAc modified proteins in vivo (207). NagZ was identified to be the 
molecular saboteur responsible for cleaving O-linked GlcNAc from proteins. This 
further supports the idea that NagZ could alter protein glycosylation on the surface of 
GC, and hence alter biofilm formation. In order to test this idea, I constructed a pglC 

















Figure 3.23 Role of PglC-dependent glycosylation in gonococcal biofilm formation. (A) 
Relative biomass of static biofilm formed by FA1090 wildtype, ΔpglC, ΔnagZ, and 
ΔnagZΔpglC double mutant strain. (B) Relative biomass of static biofilm formed by ΔpglC, 
ΔnagZ, and ΔnagZΔpglC double mutant strain before and after treatment with purified NagZ 
and DNase. Data represents mean values (± SE) of three independent experiments performed 






promiscuity of the pilin glycosylation system showing that more than 15 proteins 
were glycosylated in a PglC-dependent manner. I compared the biofilm formation 
between FA1090 and FA1090ΔpglC. Figure 3.23 (Panel A) shows that loss of pglC 
resulted in a significant reduction of biofilm formation of N. gonorrhoeae FA 1090. 
The same effect was observed on ΔnagZ background. Loss of pglC resulted in 
abrogation of the increased in biofilm formation caused by deletion of nagZ. Figure 
3.23 (Panel B) shows the effect of NagZ and DNase treatment on N. gonorrhoeae FA 
1090 ΔnagZ, ΔpglC and ΔpglC nagZ strains. While DNase has a very potent effect on 
all three strains in degrading biofilm, NagZ has maximal effect only on ΔnagZ strain. 
While NagZ treatment causes statistically significant reduction in the other two 
strains, the reduction is minimal suggesting that NagZ requires the bacterial surface to 
be glycosylated to have its full effect.  
3.4 Discussion 
 N. gonorrhoeae and N. meningitidis can form biofilms in vivo and in vitro, 
however the mechanism by which they are formed, and the processes that mediate 
their dispersal remain unclear. Zweig and coworkers demonstrated that secreted 
single-stranded DNA is involved but not required in the initial phase of biofilm 
formation and is not retained in the biofilm as it matures (80). Furthermore, they 
showed that the organizational role of ssDNA is taken over by other components in 
the later stages of biofilm formation. Steichen and coworkers showed that gonococcal 
biofilms contain DNA and that Nuc nuclease appears to play a crucial role in biofilm 




exogenously added DNase significantly impacts gonococcal biofilm. My studies also 
indicate that exogenously added NagZ results in destruction of preformed biofilms, 
and in its absence, the biofilms continue to accumulate over time.  Since NagZ is 
cytosolic, and only seen in culture supernatants of stationary phase gonococci, this 
further supports the conclusion that older gonococcal biofilms underdo significant 
decay due to autolysis. While NagZ has been shown to play a role in peptidoglycan 
(PG) turnover in other organisms, this report is the first to demonstrate its ability to 
degrade a biofilm. Since strain FA1090 lacks the type IV secretion system common to 
most gonococcal strains, this raises the question as to the source of extracellular DNA 
in young biofilms (74).  The data in figure 3.9 shows a striking difference between 
early biofilms produced by FA1090 and FA1090ΔNagZ.  In N. meningitidis, early 
DNA release from a small fraction of cells was mediated by cell wall-modifying 
enzymes and was crucial for initial biofilm formation (76). In FA1090ΔNagZ, biofilm 
organization does not differ from the wildtype until some of the bacteria in the culture 
until 24 to 48 hours suggesting that the increase in biofilm formation depends on 
DNA released by autolysis.  The presence of DNA in FA1090ΔNagZ biofilms was 
readily visualized in the biofilm by SEM.   
         My SEM data corresponds to a relatively young biofilm (36 hrs), made by strain 
FA1090.  This biofilm appears similar to those made by N. gonorrhoeae FA19 but 
significantly different from biofilms formed by strain 1291 after 48 hrs (87, 118, 
202).  In this older 1291 biofilm, gonococci appear to have a significant degree of 
membrane blebbing and cellular debris, more in line with our 72 hr biofilms (66).  




images are reflective of a dying biofilm, with the observed debris due to cellular lysis 
(66). Greiner et al. indicated that when gonococci form biofilms in the absence of 
CMP-Neu5ac, the terminal sugar of the biofilm matrix contains either a β-linked N-
acetylglucosamine or galactose (88).  Because NagZ was unable to cleave neisserial 
LOS, the glycosylated moiety of the matrix cannot be LOS.  Vik et al. have shown 
that N. gonorrhoeae possesses a wide repertoire of glycosylated proteins aided in part 
by a set of promiscuous glycosyltransferases (121).  In subsequent work they 
expanded this to a total of 19 known glycoproteins (211).  Faridmoayer et al. 
demonstrated that the meningococcal protein PglL, the protein responsible for 
oligosaccharyl transfer of sugars to pilin is a promiscuous enzyme able to mediate the 
transfer of a variety of carbohydrates, including peptidoglycan fragments, to pili 
(212).  Since pglL is an ortholog of the gonococcal gene pglO, this would suggest that 
peptidoglycan fragments and other carbohydrates could be added to a variety of 
surface expressed proteins, which could serve as the source of β-linked N-
acetylglucosamine. Further, allelic variations in pglH, which encodes a protein 
involved in pilin glycosylation downstream of pglC, was observed to result in 
addition of N-acetylglucosamine, which is the primary substrate for NagZ (122).          
Since many of these proteins are surface expressed, they could promote 
bacteria-bacteria interactions.  Glycosylation of surface proteins has been shown to 
promote bacterial aggregation in other species as well (123). I hypothesize that NagZ 
could be acting on some of these proteins, functionally acting as a biofilm dispersing 
agent. NagZ has been shown to be able to act upon glycoproteins (207). In my 




moieties by various promiscuous glycosyltransferases can promote bacteria-bacteria 
interaction and this interaction is interrupted by NagZ that destroys peptidoglycan 
monomers (Figure 3.22). The glycan diversity observed on gonococcal surface is 
further compounded by the observation that NagZ exhibits endoglycosidase activity 
in addition to its exoglycosidase activity (Figure 3.1). Previously another 
hexosaminidase (dispersin B), belonging to GH 20 family, has been shown to cause 
dispersal of Actinobacillus actinomycetemcomitans biofilm (213).  Dispersin B was 
found to cleave a polymer of N-acetylglucosamine with β-(1,6) linkage, present in the 
extracellular polysaccharide (EPS) matrix of A. actinomycetemcomitans.  However, 
Dispersin B had no effect on gonococcal biofilms, indicating that the GlcNAc on 
gonococcal surface was not β-(1,6) linked. 
         I also created an ex vivo model to study biofilm formation using human cervix 
tissue obtained from women undergoing hysterectomy. Using SEM this is the first 
study showing biofilm formation on human cervix tissue as well as polarized 
epithelial cells. The biofilm formation on abiotic surfaces as well as biotic surface 
correlated in this study suggesting that interaction with epithelial cells did not modify 
biofilm formation significantly. However, quantifying biofilm formation on cervix 
tissue is technically challenging because of mucus secretion and sloughing of 
epithelial cells. Using SEM on cervix explants, I observed significant epithelial 
sloughing which suggests that gonococci seldom form biofilm in vivo without causing 
significant damage to epithelial cells. It is possible that damage to epithelial cells is 
limited by biofilm dispersal mediated by enzymes such as nuclease and NagZ. One of 




are able to produce asymptomatic infections in women, especially since it appears to 
be growing as a biofilm on cervical specimens.  While the gonococcus possesses all 
of the requisite surface molecules needed to induce an innate immune response, they 
fail to induce a strong proinflammatory cytokine response in infected women (214).  
Studies of cytokine induction by the gonococcus show that in fallopian tube tissue, 
there is an increase in IL-1β, IL-8, and tumor necrosis factor (TNF)-α (215).  TNF-α 
was also found to correlate with tissue damage that occurs during infection (176, 
216).   
 Since N-acetylglucosamine suppresses neutrophil functions and 
proinflammatory cytokine induction, and NagZ has been shown to be capable of 
removing N-acetylglucosamine from glycosylated proteins, this would suggest that 
liberation of N-acetylglucosamine from host and bacterial proteins by NagZ can serve 
to suppress the immunological signaling when the gonococcus colonizes cervical 
mucosa (217, 218). This was evident when the wildtype strain appeared to cause 
more sloughing of epithelial cell than nagZ mutant strain. In the gonococcus, I 
propose a model for biofilm formation that is regulated by interplay of biofilm 
promoting factors such as glycosyltransferases, Type IV secretion system (which 
releases eDNA), pilin, Opa and anti-biofilm factors such as NagZ and Nuc DNase. 
Bacterial dispersal from biofilm is not only important for disease transmission but is 
necessary for causing invasive and/or ascending infection, because released bacteria 






Chapter 4: N. gonorrhoeae interaction with epithelial cells 
induces activation of inflammasome and inflammasome-
dependent cytokine production 
4.1 Introduction  
         Epithelial cells also express pattern-recognition receptors such as Toll-like 
receptors (TLRs) and NOD-like receptors (NLRs) (128). TLRs are evolutionarily 
conserved transmembrane proteins that recognize either exogenous PAMPs or 
endogenous danger-associated molecular patterns (DAMPs). Activation of TLRs by 
extracellular or membrane-bound PAMPs results in expression of NF-κB- and AP-1-
mediated cytokine production. Inflammasome is a multiprotein complex that is 
formed in response to cytosolic danger signals and induces maturation and release of 
inflammatory cytokines such as IL-18 and IL-1β.  Inflammasome activation requires 
two signals. An initial priming signal, mediated by TLRs, induces expression of 
NLRs, pro-IL-1β and pro-IL-18. The second signal, generated by an unidentified 
mechanism, triggers the assembly of NLRs, ASCs and pro-caspase 1. This assembly 
activates caspase 1 that cleaves pro-IL-1β and pro-IL-18 into their active forms. 
Inflammasome activation results in a highly inflammatory response, characterized by 
neutrophil infiltration.  
 Symptomatic gonorrhea is an inflammatory disease characterized by 
neutrophil infiltration and purulent discharge. However, numerous patients exhibit no 




immunosuppressive signaling pathways are activated in B and T lymphocytes 
resulting in lack of protective immunity (219). Studies on human subjects are limited 
due to ethical and financial concerns. Limited studies on male subjects have shown 
detectable levels of IL-1β in urine, suggesting the involvement of inflammasome 
activation in GC-induced inflammation. Similar observations were made in urethral 
cell lines and immortalized human epithelial cells from the FRT. The paradoxical 
observation between a locally inflammatory response and a lack of protective 
immunity post GC infection are not yet understood.  
         This study aims to understand the role of inflammasome activation in epithelial 
cell-mediated cytokine response against gonococci. Duncan et al have shown that N. 
gonorrhoeae can activate NLRP3 inflammasome in monocytes by causing activation 
of the cysteine protease cathepsin B by an unknown mechanism (174). LOS was 
implicated as an activator of NLRP3 inflammasome. While human studies have 
showed that IL-1β levels in urine correlate with clinical symptoms in male patients, it 
is unclear whether inflammasome is involved in cytokine production in the epithelial 
cells of the FRT. This study used both human cell line and cervix explants culture to 
analyze the relationship of epithelial cytokine production and inflammasomes and 
TLRs in gonococcal infection.  
         This study shows that gonococci can activate the inflammasome in epithelial 
cells in culture and in human cervical tissue explants. Gonococcal interactions also 






4.2 Materials and Methods 
4.2.1 Fluorescent inhibitor of Caspase 1 Assay (FLICA)  
         This assay is based on using a probe a caspase 1-specific amino acid sequence 
tagged to fluoromethylketone (FMK), a fluorescent moiety (220). The cell permeable 
probe enters cells and binds only to activated caspase 1 and inhibits it. Unbound 
probes are washed. Briefly, 105 cells per 96 well plate are seeded three days before 
the experiment. Cells are washed with fresh media without antibiotic on the day 
before the experiment and treated with bacteria at an MOI of 10 for 6 hours. After 6 
hours, the media was removed, the fluorescent probe suspended in PBS is added to 
the cells and incubated for an hour at 37º C. The cells were then washed with PBS for 
5 times and fixed with 4% paraformaldehyde before fixing on a glass slide. Slides 
were visualized within 24 hours as specified by the manufacturer of the kit 
(Immunochemistry Technologies, USA).  
4.2.2 Measuring cytokines produced by epithelial cells  
         For measuring cytokine produced by epithelial cells, 10e5 cells were seeded per 
well on a 96 well plate three days before the experiment. Fresh media without 
antibiotics was added the day before the experiment. Bacteria were added to each 
well at an MOI of 10. The cells were treated with bacteria for 24 hours, supernatant 
collected and debris spun down. The supernatant was stored at -80º C until needed, 
after adding protease inhibitor (Roche). For ELISA, the supernatant was thawed out 




Ready-SET-Go kit and IL-1β was measured using R&D Systems’ kit. Instructions by 
the kit manufacturer were used for all the experiments. 
4.2.3 Measuring cytokines produced by cervical explant tissue  
         Cervical tissue was obtained with consent from volunteer donors undergoing 
hysterectomy. The cervical chunks were cut into cylindrical blocks of tissue using a 
6.5mm diameter biopsy punch. The cervical tissue chunks were separated as 
endocervix and ectocervis and placed inside a transwell insert in 24 well tissue 
culture plates. 24 hours later bacteria was added to the cervix chunks and incubated 
for 24 hours. After 24 hours, the supernatant was removed, debris spun out and stored 
the same way as above. The supernatant was used for ELISA as described above.  
4.3 Results 
4.3.1 GC activates inflammasome in epithelial cells  
         In order to determine if gonococcal interactions with epithelial cells will 
activate the inflammasome, epithelial cell lines, HEC-1B and T84, were incubated 
with N. gonorrhoeae MS11 (Opa-expressing and piliated strains were used) for 6 
hours. The activation of inflammasomes was detected by the activation of caspase 1. 
Activated caspase 1 was detected using a fluorescent-labeled peptide YVAD that 
binds to activated caspase 1 (FLICA). The detection probe contains the YVAD 
peptide moiety that irreversibly binds with the activated caspase enzyme. A non-
fluorescent probe with the WEHD peptide sequence which is also recognized by 










Figure 4.1 Gonococci activate caspase 1 in epithelial cells Figure 4.1 Gonococci activate 
caspase 1 in epithelial cells (A) Representative confocal image of non-polarized T84 
epithelial cells either untreated (NC), or treated with gonococci (GC)(MOI:10), or 
staurosporine (STR)(10µM) or gonococci plus non-fluorescent inhibitor of caspase 1 (GC + 
WEHD)(10µM). Cells were then stained for activated caspase 1(Red) and nucleus (Blue), 
fixed and visualized by confocal microscopy. Scale bar corresponds to 10 µm. (B and C) The 
percentage of cells that were positive for activated caspase 1 (FLICA+) after no treatment or 
treatment with GC or STR in T84 cells (panel B) and HEC-1-B cells (panel C) from three 














Figure 4.2 GC induce IL-8 production in epithelial cells.  Non-polarized T84 cells (panel 
A) and HEC-1-B cells (panel B) were treated with GC (MOI: 10) alone or GC DNA (50 
µg/mL) or GC + GC DNA or GC + GC DNA + WEHD (10 µM) and supernatant assayed 
after 24 hours for IL-8.  (C) IL-8 levels in the presence and absence of MyD88 inhibitor (200 
µM) after T84 cells were treated with either GC alone or GC DNA alone. Results shown are 
the mean (± SEM) of three independent experiments (* p < 0.05, ** p < 0.01, *** p < 0.001, 




FLICA staining, indicating activation of caspase 1, was detected as fluorescent spots 
in the cytoplasm of epithelial cells incubated with either GC or staurosporine but not 
untreated cells (Figure 4.1A). The FLICA staining was abolished in epithelial cells 
pretreated with competing non-fluorescent caspase 1-specific probe, confirming that 
the specificity of FLICA to activated caspase 1. The relative level of caspase 1 
activation was evaluated by the percentage of FLICA-positive cells (Fig. 4.1B). 
Compared to untreated epithelial cells, GC infection significantly increased the 
percentages of both T84 (~75%) and HEC-1-B cells (~50%) showing caspase 1 
activation. The percentages of GC-infected epithelial cells with activated caspase 1 
were similar to that of staurosporine-treated cells. These results indicate that GC 
interactions induce inflammasome activation in epithelial cells. This is consistent 
with previous studies on THP-1 cells, which showed that GC was able to activate 
caspase 1 (174). 
4.3.2 GC infection induces IL-8 production in epithelial cells  
         Symptomatic gonorrhoeae is characterized by neutrophil recruitment and severe 
inflammation. However, patients suffering from asymptomatic disease show a lack of 
neutrophil recruitment. IL-8 functions as a chemokine for neutrophils and other 
immune cells. To determine whether GC infection induce IL-8 production in 
epithelial cells, epithelial cell lines, HEC-1-B and T84, were treated with N. 
gonorrhoeae MS11 for 24 hours at a starting MOI of 10. IL-8 secreted into culture 
media was measured using ELISA.  After incubation with GC, the concentrations of 
IL-8 were significantly higher in both cell lines, compared to their no infection 




detected no significant effect of GC chromosomal DNA on IL-8 production in HEC-
1-B cells, it modestly increased IL-8 production in T84 cells. To determine whether 
GC-induced IL-8 production in epithelial cells is mediated by Toll-like receptors 
(TLRs), I inhibited the common adaptor proteins of TLRs MyD88, using a peptide 
inhibitor. The treatment of MyD88 inhibitor significantly reduced GC-induced IL-8 
production in T84 cells (Figure 4.2C). Our results indicate that GC interactions 
induce the production of IL-8 by epithelial cells in a TLR-dependent manner. 
4.3.3 GC-induced IL-8 production is independent of inflammasome 
activation 
         We have shown that GC was able to induce both the activation of 
inflammasome and TLR-dependent production of IL-8 in epithelial cells. I examined 
if there was any interaction between the two pathways by analyzing the effect of the 
caspase 1 inhibitor WEHD on GC-induced IL-8 production. The treatment of 
epithelial cells with caspase 1 inhibitor did not significantly change IL-8 induction 
levels in GC infected cells. This result suggests that inflammasome activation is not 
responsible for and does not affect IL-8 production. 
4.3.4 GC interactions induce the production of IL18 in epithelial cells in an 
inflammasome-dependent manner 
         Activation of inflammasome results in downstream activation of caspase 1, 
which produces activated IL-18 and IL-1β by cleavage of their proforms. In order to 


















Figure 4.3 IL-18 production by non-polarized HEC-1-B cells. HEC-1B were untreated or 
treated with gonococci (GC) or enteropathogenic E. coli (EPEC) at an MOI 10 for 24 hrs and 
supernatant assayed for IL-18 by ELISA. EPEC was used as positive control and NC is 
untreated sample. GC-treated and EPEC-treated HEC-1-B cells were also co-incubated with 
caspase 1 inhibitor zYVAD-FMK (10 µM) and IL-18 measured. Results are mean (± SE) of 






to N. gonorrhoeae, I measured their levels in the supernatant of GC-epithelial co-
cultures using ELISA. While no IL-1β production was detected in both epithelial cell 
lines, the level of IL-18 in GC inoculated HEC-1-B cells was significantly higher than 
those cells without bacterial inoculation. No IL-18 production was detected in in T84 
cells either inoculated with GC or Enteropathogenic E. coli (EPEC) (Figure 4.3). 
EPEC was used as a positive control since it was shown to activate inflammasomes 
(221). In order to determine if GC-induced IL-18 was inflammasome activated, I 
treated HEC-1-B cells with both GC and the caspase 1 inhibitor. The treatment of the 
caspase inhibitor significantly reduced the IL-18 level (Figure 4.3B), suggesting that 
GC-induced IL-18 production by HEC-1B cells requires inflammasome-activation.  
4.3.5. GC-induced cytokine production by cervical explant tissue: In order to 
study if the results from cell lines can be replicated in human tissues, I established a 
human cervix tissue explant model. The cervix tissue explants were generated using a 
biopsy punch (6 mm diameter) and grown on transwell inserts (6.5 mm diameter). 
After incubation with GC at MOI 10 for 24 hours, supernatant was collected to 
measure IL-8 and IL-1β. Similar to the cell lines, GC inoculation induced significant 
increases in IL-8 production in the culture medium of endocervical tissue explants. 
However, I did not observe any IL-8 production by ectocervical tissue explants. 
Similar to epithelial cell lines, IL-8 production by endocervical tissue explants was 
unaffected by the caspase 1 inhibitor YVAD (Figure 4.4A). Our results show that GC 
inoculation results in the production of IL-8 from endo-, but not ecto-cervical tissue 
explants, which is independent of inflammasomes. The levels of IL-1β in the media 


















Figure 4.4 Cytokine production by cervical explant tissue. Cervical explant tissue 
(endocervix and ectocervix) were either untreated or treated with gonococci (GC) alone or 
GC + caspase 1 inhibitor (YVAD)(10 µM) for 24 hours and supernatants assayed for IL-8 
(Panel A) and IL-1β (Panel B) by ELISA. Ectocervix did not produce detectable levels of 





produce in response to GC inoculation, compared to the tissue explants without GC 
inoculation. Furthermore, the IL-1β level was significantly reduced when the tissue 
explants were treated with the caspase 1 inhibitor (Figure 4.4B). These results 
indicate that GC inoculation induces inflammasome-dependent production of IL-1β in 
both ecto- and endo-cervical tissues. 
4.4 Discussion  
         To our knowledge, this study is the first to show inflammasome activation in 
epithelial cells in response to gonococcal infection. Activated caspase 1 was detected 
using a fluorescent probe-based assay in both the epithelial cell lines used, HEC-1-B 
and T84. In addition, I show that HEC-1-B cells were able to produce the 
inflammasome-dependent cytokine IL-18 following stimulation by GC. I did not 
detect any IL-1β production by either cell line. While IL-8 production was unaffected 
by inhibiting caspase 1, IL-18 levels were significantly reduced by treating the cells 
with caspase 1 inhibitor. I also show that GC-induced IL-8 production by epithelial 
cells is MyD88-dependent as IL-8 level was reduced by MyD88 peptide inhibitor. 
Experiments performed using human cervical explant tissue showed similar findings 
in terms of IL-1β, which was reduced by caspase 1 inhibitor, which suggests that 
HEC-1-B and T84 epithelial cell lines are a biologically relevant models to study 
gonococcal infection of epithelial cells. While GC infection increased IL-8 
production by endocervix, which was unaffected by caspase 1 inhibition, ectocervical 
explant did not show any IL-8 production on infection with GC. Experiments in the 
Song lab have shown that endocervix and ectocervix have polarized and non-




difference between endocervix and ectocervix in terms of cytokine production and 
inflammasome activation.  
         While the current study is preliminary and limited, the data needs to be 
confirmed with more replications. This study shows that GC-induced IL-8 production 
by epithelial cells was caspase 1-independent and MyD88-dependent. While it is 
unclear yet how GC trigger TLR activation, multiple molecules expressed by GC are 
potential agonists of TLR, such as LOS for TLR4, Porin for TLR2, PG fragments for 
TLR2, and CpG DNA for TLR9. While our cell line experiments show that caspase 1 
activation does not affect GC-induced IL-8 production, I also observe similar results 
under ex vivo conditions using cervix tissue, where Il-8 production is unaffected by 
caspase 1 inhibition but IL-1β levels are reduced by using caspase 1 inhibitor. 
Caspase 1 activation and inflammasome activation need to be verified by western blot 
and immunofluorescence microscopy, using cell lines as well as cervical explant 
model. To further characterize the cytokine profiles of GC infected human epithelial 
cells and cervical tissue explants, I propose to use a cytokine array to screen for 
cytokines, including IL-10, IL-17, IL-23, IL-6 and TGF-β in the presence and absence 
of GC inoculation, the MyD88 inhibitor, and the caspase 1 inhibitor. This will help us 
understand the interaction between bacteria and host tissue in regulating the levels of 
proinflammatory and anti-inflammatory cytokines. Cytokine production by both 
models can be assayed using membrane-based cytokine arrays as well as bead-based 
cytokine assays. While I identified some preliminary differences between ectocervix 
and endocervix in terms of IL-8 production, similar experiments comparing polarized 




         The mechanism of inflammasome activation in epithelial cells is unknown. 
Previous work has suggested that GC LOS is responsible for inflammasome 
activation in THP-1 cells by causing activation of cathepsin B. Another possible 
mechanism could be porin-mediated calcium influx, since porin- mediated apoptosis 
of epithelial cells has been shown to be inhibited by a caspase 1-specific inhibitor 
(18). It is possible that gonococcal-induced epithelial cell death involves both 
apoptosis and pyroptosis, the latter of which is the result of inflammasome activation. 
However, the difference between apoptosis and pyroptosis has not been fully defined 
(185, 186). Our future studies will investigate the role of GC LOS and porin in the 
induction of inflammasome activation. 
         As nearly half of gonorrhea patients are asymptomatic according to CDC 
reports, it is important to study the mechanism behind asymptomatic infections. It is 
paradoxical that gonococci can activate inflammasome and result in production of 
inflammatory cytokine IL-1β. It may be resolved by examine the balance between the 
inflammatory cytokines with the anti-inflammatory cytokines such as IL-10 and TGF-
β, and their relationship with TLR and inflammasome activation. Activation of Rig-
like Receptors (RLRs) has been shown to inhibit TLR-mediated production of 
inflammatory cytokines in CD4+ T cells (187). The crosstalk between TLRs and 
inflammasome activation pathway may be critical for gonococci to manipulate host 
immune responses.  
         The function of epithelial cells and the local immune system in the female 
reproductive tract is regulated by sex hormones, which is an addition factor that can 




this thesis, our SEM analysis shows epithelial exfoliation in GC inoculated cervical 
tissue. IL-1β has been shown to play an important role in epithelial exfoliation during 
Salmonella sp. infection (188–190). While exfoliation is inflammasome mediated and 
considered protective by reducing infection load, exfoliation of cells in FRT have 
been associated with infertility (11, 222, 223). Our tissue model is ideal to understand 
the role of inflammasome in epithelial exfoliation. This work is important in the 
context of understanding how bacterial interaction with epithelial cells and cervix 
tissue ex vivo play a role in modulating mucosal immune response. The role of 





Chapter 5:  General discussion and future work 
 
5.1 General summary  
         Carbohydrates are one of the most important biological macromolecules. LOS is 
a major surface glycoconjugate in Neisseriaceae. LOS is also a crucial 
immunostimulatory agent, which interacts with TLR4 on host cell surface. In this 
study, I took a bioinformatics approach to identify the genes involved in LOS 
biosynthesis in the various species of Neisseriaceae. I used the results to predict the 
structure of LOS, based on the distribution of the various genes. My work correlates 
with experimental evidence available for some of the commensal neisserial species. I 
observed that LOS core structure fundamentally differs between neisserial pathogens 
and commensals. While the commensal strains have three heptose moieties in the 
core region, neisserial pathogens have two heptose units and a GlcNAc molecule. 
This observation based on genomic data correlates with experimental observations 
published earlier. While the reasons for the difference are not clearly understood, I 
hypothesize that selection pressure in the form of cationic antimicrobial peptides is 
driving the pathogens to reduce the overall negative charge in the core region by 
incorporating a GlcNAc instead of another heptose. This change, I hypothesize, 
incidentally makes the LOS easy to extract from the outer membrane and hence more 
immunostimulatory. Experiments, as described earlier using BODIPY-LOS, need to 
be performed to understand differences in LOS extraction by host LPS-binding 
proteins.  




MIC and loss of GlcNAc decreases polymyxin MIC by fourfold in neisserial 
commensals and pathogens respectively. The overall surface charge can be estimated 
in future experiments in the two mutant strains. I also propose to introduce the 
putative waaQ gene, which encodes the third heptosyltransferase, into N. 
gonorrhoeae and rfaK, which adds GlcNAc, into N. sicca 4320. Testing of TLR4 
stimulation using these strains will further help us test our hypothesis.  
         Epiproteomic modification with carbohydrates has been well-studied in 
eukaryotes. The significance of protein glycosylation is recognized and the incredible 
complexity in its regulation and modulation has led its regulation to be dubbed ‘the 
quantum mechanics of biology’ (224). In contrast, bacterial protein glycosylation is 
only now being studied. Bacterial glycosylation, similar to prokaryotes, involves both 
O-glycosylation and N- glycosylation (225). A significant point of departure is that 
bacterial glycosylation appears to have a more diverse glycan structure, aided in part 
by promiscuity in donor- and acceptor-specificity of glycosyltransferases (225). 
While N-glycosylation has been studied in Campylobacter jejuni, N. gonorrhoeae has 
been the candidate bacteria to understand O-glycosylation. Gonococci has been 
shown to add diacetamido-2,4,6- trideoxyhexose (DATDH), followed by one to two 
galactose to its glycosylated proteins. The glycosylation mechanism has also been 
shown to glycosylate nearly 20 different proteins on the surface of N. gonorrhoeae 
(121, 211). Adding to the surface diversity is phase variation of genes involved in the 
glycosylation pathway. In this study, I show how this promiscuous protein 
glycosylation is modulated by NagZ, which has previously only been shown to be 




shows that proteins with known function intracellularly or in periplasm could 
potentially have a novel function extracellularly. I show that while absence of NagZ 
results in increased biofilm formation, possibly to due to lack of ability to 
deglycosylate the surface proteins, this increase is in biofilm formation disappears 
when both NagZ and PglC are knocked out. NagZ deletion does not change alter 
bacterial growth rate, survival or blebbing. I also show that gonococci are able to 
form biofilm on the surface of polarized epithelial cells by using scanning electron 
microscope. While others have demonstrated gonococcal biofilm formation on 
epithelial cell models and glass surfaces, this is the first study to show biofilm 
formation on polarized epithelial cells (88, 118, 202). 
         In the final part of the study, I show that gonococci induce production of 
inflammatory cytokines such as IL-8, IL-18 and IL-1β in cell culture models as well 
as cervical explant tissue model. While IL-8 production appears to be affected by 
MyD88 inhibition, the caspase 1-dependent cytokines IL-18 and IL-1β unaffected by 
MyD88 inhibition. While gonococci activate the inflammasome by an unknown 
mechanism involving LOS-mediated cathepsin B activation in human monocytes, I 
demonstrate that gonococci are able to activate inflammasomes in epithelial cells 
(174). This study establishes inflammasome activation in epithelial cells and 
production of inflammasome-mediated cytokines IL-18 and/or IL-1β in epithelial 















Figure 5.1 Working model of biofilm modulation and its role in gonorrhea. Biofilm 
formation on epithelial surface is regulated by NagZ and Nuc. Inset image shows working 






5.2 Working Model 
         Based on the findings from my experiments, I propose the following working 
model. Gonococcal infection begins in the cervical region of FRT following sexual 
transmission. Initially the bacteria aggregate and form microcolonies on the surface of 
epithelial cells. These aggregates were reported by Apicella et al, on the cervical 
biopsy samples (87). However, as bacteria begin forming biofilm there is significant 
sloughing of epithelial cells as I observed on SEM experiments using cervical explant 
tissue (Figure 3.14). Other workers have also reported GC-mediated sloughing of 
epithelial cells using fallopian tube explants (176, 216). In order to limit sloughing 
and to continue colonization, bacteria use proteins such NagZ and Nuc nuclease to 
limit biofilm formation. The role of Nuc protein in limiting gonococcal biofilm has 
earlier been shown (118). In addition, prevention of sloughing of epithelial cells also 
means that the bacteria that are already attached to epithelial cells are not lost. Our lab 
has already established that gonococcal strains that do not aggregate are able to cross 
the epithelial monolayer in a more efficient fashion compared to strains that form 
large microcolonies.  
         My work has shown that NagZ-deficient strains form a thicker and denser 
biofilm, suggesting that NagZ plays a role in limiting formation of large 
microcolonies and promote bacterial escape from biofilm. These escaping bacteria are 
now free to either cross the epithelial layer and result in locally invasive disease or 
ascend into the FRT and cause PID. The free bacteria are also now available to cause 
disseminated gonococcal infection (DGI), since they are not held down by the 




cervix and blood of the same patient have shown that the cervical isolates form a 
thicker biofilm than blood isolates (Nadia Kadry, unpublished observations). 
However, there is no evidence yet of the proteins that are modulated by NagZ, 
although evidence exists that NagZ can remove GlcNAc from not just PG monomers 
but also glycosylated proteins in E. coli (207). Further experiments will be carried out 
using lectin-binding studies to identify the glycosylated proteins that are involved. 
The evidence suggesting that surface glycoproteins (and not LOS) comes from the 
observation that loss of NagZ in the absence of PglC did not increase biofilm 
formation (Figure 3.23) and that NagZ had no effect on LOS (Figure 3.21). It is also 
possible that released peptidoglycan monomers could as cement and promote 
bacterial aggregation and subsequent biofilm formation.  
         Gonococci are in intimate contact with epithelial cells during infection, resulting 
in activation of TLR and other PRRs in epithelial cells (173, 182). I have shown that 
GC can also activate inflammasomes in epithelial cells, although the mechanism 
behind inflammasome activation is not known yet. It has been suggested that 
gonococcal LOS could activate cathepsin B by an unknown mechanism resulting in 
inflammasome activation. However, it is still not known if LOS structure affects 
inflammasome activation since gonococci have significant diversity in LOS structure. 
In addition, the inflammasome protein that is activated also needs to be identified. 
While preliminary work suggests that inflammasome activation has no effect on 
TLR-mediated cytokine production, such as IL-8, the possible interaction between 
these two pathways needs to be characterized. The role of biofilm formation also 




escape from immune response. Further studies need to be carried to answer these 
questions.  
         Taken together, my thesis demonstrates the diversity of surface 
lipooligosaccharides in Neisseriaceae, the role of glycoconjugates and their 
modulation by NagZ in gonococcal biofilm formation and finally activation of 
inflammasomes in epithelial cells by GC. This underlines the significant role played 
by glycosylated moieties in host-pathogen interaction.  
5.3 Future Direction 
         The general focus of my research has been on the role of surface glycosylated 
moieties on the pathogenesis of gonorrhea. In the first part, I showed the diversity of 
LOS structure using in silico techniques among the various species in Neisseriaceae 
and identified a key difference in LOS core region between commensals and 
pathogens of Neisseriaceae (22). The second part involves characterizing a protein 
previously thought to be involved in peptidoglycan recovery and identifying its role 
in modulation of biofilm formation. While the mechanism of action of this protein is 
not completely understood, evidence suggests that NagZ is acting on surface 
glycosylated proteins and NagZ’s action is dependent on PglC-mediated surface 
protein glycosylation. In the final part, I demonstrate preliminary evidence for 
inflammasome-mediated activation of caspase 1 by gonococci in epithelial cells and 
show production of caspase 1-dependent cytokines following gonococcal infection. 
These findings while helping us understand gonococcal pathogenesis have also raised 




5.3.1 Question 1: How does LOS inner core difference modulate LOS-
TLR4 interaction?  
         My study shows that there is conservation of LOS structure in neisserial 
commensals and pathogens. Neisserial pathogens and closely related species had the 
potential to decorate their LOS with phosphoethanolamine, sialic acid and acetic acid. 
In addition, neisserial pathogens and commensals had major differences in the way 
their LOS core region is synthesized. Jarvis et al have shown that neisserial pathogens 
and commensals differ in their ability to induce TLR4-mediated cytokine in THP1 
cells. Taken together, these suggest that the differences I have identified could 
explain the mechanism behind the difference observed by other researchers. 
However, the exact molecular mechanism behind the difference and how the 
difference in core structure would affect TLR4 activation is still unknown. I 
hypothesize that the changes in core structure will alter the overall charge of LOS 
core and affect extraction of LOS from outer membrane by host proteins such as 
LBP. This hypothesis can be tested by using making mutants in commensal strains 
such that their LOS structure now resembles that seen in pathogenic strains, and 
looking at their ability to activate TLR4. Preliminary work by me has shown that 
knocking out waaQ gene increases the ability of N. sicca 4320 to activate TLR4 and 
knocking out rfaK reduces TLR4 activation by N. gonorrhoeae F62 strain. Further 
biochemical analysis needs to be done with BODIPY-tagged LOS molecules that will 
aggregate in solution and not fluoresce until extracted by LBP. Understanding the 
role of LOS inner core region in LOS extraction would help us develop better vaccine 




understanding of structure-function relationship in neisserial LOS. 
5.3.2 Question 2: Does surface glycosylation affect biofilm formation by 
modulating the behavior of surface adhesins or does it also affect eDNA-
mediated biofilm formation? 
         My research work has shown that glycosylation of surface proteins is necessary 
for promoting bacterial interaction and biofilm formation. Bacterial glycosylation has 
not been studied as much as glycosylation in eukaryotic systems. The role of surface 
glycosylation in modulating bacteria behavior has been observed workers as well. 
Iwashkiw et al show that loss of pglL in Acinetobacter baumanii results in inability to 
form a thick biofilm as well loss of virulence in infection models (226). Similarly, 
glycosylation of adhesins has been shown to enhance their function in bacteria-
bacteria interaction as well as bacteria-host cell interaction. Defects in glycosylation 
of the fimbrial protein Fap1 resulted in reduced biofilm formation in Streptococcus 
parasanguinis (124, 227). Similar effects on biofilm formation were observed in 
Aeromonas hydrophila and Porphyromonas gingivalis (228, 229). While I have 
characterized the effect of glycosylation, modulation of surface glycosylation by 
NagZ and its effect on biofilm formation, the surface target or targets that play a role 
in this interaction are yet to be characterized. Future work will identify the surface 
glycoconjugates that regulate initial aggregation and subsequent biofilm formation. It 
also needs to be understood if it is the same glycosylated proteins that promote initial 
aggregation as well as subsequent biofilm formation or if there are multiple surface 
molecules that affect the various stages of biofilm formation differentially. In 




DNA attachment to gonococci, since eDNA has been shown to play an important role 
in gonococcal biofilm formation (118).  
5.3.3 Question 3: Does NagZ alter gonococcal interaction with epithelial 
cells? 
         My work has demonstrated that the intracellular protein NagZ is available 
extracellularly in stationary-phase grown gonococci. This has many implications in 
terms of novel functions for many intracellular enzymes. Based on these findings, I 
hypothesize that NagZ could also deglycosylate glycoconjugates on the surface of 
epithelial cells, and this deglycosylation could potentially modulate GC interaction 
with host cells in multiple ways. E. coli OmpA has been shown to interact with 
GlcNAc β 1−4 GlcNAc epitope on endothelial cell surface resulting in enhanced 
bacterial invasion (230). The Opa proteins in N. meningitidis and N. gonorrhoeae   
promote invasion of cells and act as lectins as well, suggesting that NagZ could not 
only promote bacterial dispersal but also invasion into epithelial cells (38, 44). This 
can be tested by using wheat germ agglutinin (which binds to terminal GlcNAc) to 
pretreat epithelial cells and perform and epithelial invasion assay using gonococci. 
GC has also been shown to release highly inflammatory peptidoglycan fragments, 
which activate TLR2 and NOD1(176, 231, 232). I have shown that purified NagZ 
was able to remove the terminal GlcNAc from immunostimulatory PG monomer 
fragments. I hypothesize that NagZ would be able to detoxify PG monomers and 
could contribute to reducing inflammation, which could explain the significant 
number of patients suffering from subclinical gonorrhea. Further, the role of GlcNAc 




has also been reported to curtail inflammatory response (233). Studying the role of 
free GlcNAc and the role of NagZ modulation of epithelial cell surface glycosylation 
would help us uncover novel mechanisms used by bacteria in surviving immune 
response. 
5.3.4 Question 4: How does GC not elicit a potent inflammatory response 
in FRT even though it is able to activate inflammasomes?  
         In the final part of thesis, I show activation of inflammasomes in epithelial cells 
by gonococci. Previously Duncan et al have shown inflammasome activation in 
monocytic cell line by GC (174). Inflammasome activation has been shown to result 
in production of significant amount of the highly pro-inflammatory cytokines IL-1β 
and IL-18, which (along with IL-8) recruit neutrophils and initial a cascade of 
inflammatory responses. Almost half the number of patients with gonorrhea escape 
clinical diagnosis, according to CDC estimates, which suggests that gonococci do not 
elicit a strong inflammatory response (177). The mechanism behind this paradoxical 
observation needs to be resolved to understand the host response and develop 
vaccines against gonorrhea. It is possible that inflammasome activation is also 
resulting in pyroptosis of epithelial cells and local immune cells (174). However, this 
could only explain the lack of protective long-term immunity and does not explain the 
lack of a local acute inflammatory response in a significant patient population. NagZ-
mediated cleavage of PG monomers and release of free GlcNAc could play a role as 
GlcNAc has been shown to diminish IL-1β-mediated activation of chondrocytes 
(233). In addition, GC induced production of anti-inflammatory cytokines such as IL-




inflammatory cytokines such as IL-8 and TNF-α, mediated by TLR activation (35, 
182). The interaction between the different pathways involved in production of NF-
κB-dependent cytokines and caspase 1-dependent cytokines has to be investigated to 
understand host response. My preliminary experiments have established that 
epithelial cell lines can be used along with human cervical explant model to study 
host immune response. Future experiments need to performed with polarized 
epithelial cells to understand if polarity affects immune response since TLR 
distribution is affected by polarity of epithelial cells. In addition, polarity has also 
been shown to be associated with mucin production in other cell lines, which could 
further hamper access to TLR (234). Future studies on our ex vivo model using cervix 
tissue will further our understanding of host response in gonococcal infection, which 







1. List of strains prepared 
N. gonorrhoeae F62 ΔrfaK   rfaK is deleted, resulting in LOS 
truncation and absence of GlcNAc in LOS core region. 
N. gonorrhoeae F62 ΔlgtF   lgtF gene is deleted, resulting in 
truncation of LOS 
N. sicca 4320 ΔwaaQ    waaQ gene, which adds a third 
heptosyltransferase to the LOS core in N. sicca 4320 is deleted.    
N. gonorrhoeae 1291 Δlpt3   Inability to add to PEA to the second 
heptose in the LOS core at 3rd position 
N. gonorrhoeae 1291 Δlpt6   Inability to add to PEA to the second 
heptose in the LOS core at the 6th position 
N. gonorrhoeae 1291 Δlpt3Δlpt6   Both lpt3 and lpt6 are deleted, resulting 
in complete lack of PEA in LOS core region 
N. gonorrhoeae MS11 ΔnagZ  Deletion of nagZ gene 
N. gonorrhoeae F62 ΔnagZ   Deletion of nagZ gene 
N. gonorrhoeae F62 ΔpglC   pglC has been knocked out resulting in 
inability to glycosylate surface proteins 
N. gonorrhoeae FA1090 ΔpglCΔrfaK pglC has been knocked out resulting in 
inability to glycosylate surface proteins and rfaK gene has been deleted resulting in a 















Figure 1. Biofilm formation by Opa mutant and ΔrfaK strains. Relative biomass formed 
by 48 hour static biofilm formed by (A) N. gonorrhoeae MS11 Opa-expressing strain and N. 
gonorrhoeae MS11 ΔOpa strain, and (B) N. gonorrhoeae F62 wildtype and N. gonorrhoeae 
F62 ΔrfaK strains. Data is mean (with SEM) of three independent experiments and analyzed 
















Figure 2. Biofilm formation by DGI isolates. Absorbance measured at 590 nm of 48 hour 
static biofilm formed by DGI blood and DGI cervical isolates from the same patient, after 
















Figure 3. IL-8 production in polarized HEC-1-B cells. Polarized HEC-1-B cells were 
treated with GC alone or GC DNA or GC + GC DNA or poly (I:C)(25 µg/mL) or poly 
(I:C) + GC. Supernatant media was collected (after 24 hours of incubation) from apical and 
basolateral sides and assayed for IL-8. Phorbolmyristate (PMA) was used as a positive 
















Figure 4. IL-8 production in non-polarized T84 cells. T84 cells were left untreated or 
treated with GC alone or GC and NLRP3 inhibitor Glibenclamide (25 µg/mL) or GC and 
Cathepsin B-inhibitor Ca-074 me (10 µM) or GC and YVAD (10 µM). Supernatant media 



















Figure 5. IL-8 production in non-polarized HEC-1-B cells. HEC-1-B cells were left 
untreated or treated with GC alone or GC and NLRP3 inhibitor Glibenclamide (25 µg/mL) or 
GC and Cathepsin B-inhibitor Ca-074 me (10 µM). Supernatant media was collected (after 24 
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